JP2000063227A - Agent for stimulating degradation of lipid and skin preparation for external use and for slimming body - Google Patents
Agent for stimulating degradation of lipid and skin preparation for external use and for slimming bodyInfo
- Publication number
- JP2000063227A JP2000063227A JP10250422A JP25042298A JP2000063227A JP 2000063227 A JP2000063227 A JP 2000063227A JP 10250422 A JP10250422 A JP 10250422A JP 25042298 A JP25042298 A JP 25042298A JP 2000063227 A JP2000063227 A JP 2000063227A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- thistle
- oil
- acid
- poe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 150000002632 lipids Chemical class 0.000 title abstract description 11
- 230000015556 catabolic process Effects 0.000 title 1
- 238000006731 degradation reaction Methods 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 114
- 235000014435 Mentha Nutrition 0.000 claims abstract description 4
- 241001072983 Mentha Species 0.000 claims abstract description 4
- 241000132536 Cirsium Species 0.000 claims description 102
- 239000000419 plant extract Substances 0.000 claims description 15
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 12
- 230000004130 lipolysis Effects 0.000 claims description 11
- 235000008184 Piper nigrum Nutrition 0.000 claims description 9
- 241000207199 Citrus Species 0.000 claims description 8
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 claims description 7
- 241000721662 Juniperus Species 0.000 claims description 7
- 241000190021 Zelkova Species 0.000 claims description 7
- 235000020971 citrus fruits Nutrition 0.000 claims description 7
- 230000001737 promoting effect Effects 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 241000219317 Amaranthaceae Species 0.000 claims description 4
- 235000002566 Capsicum Nutrition 0.000 claims description 4
- 240000006927 Foeniculum vulgare Species 0.000 claims description 4
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 4
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 4
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 4
- 239000006002 Pepper Substances 0.000 claims description 4
- 235000016761 Piper aduncum Nutrition 0.000 claims description 4
- 235000017804 Piper guineense Nutrition 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 235000020710 ginseng extract Nutrition 0.000 claims description 4
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 claims description 4
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical class N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims description 3
- 241001474374 Blennius Species 0.000 claims description 3
- 244000165082 Lavanda vera Species 0.000 claims description 3
- 229930013930 alkaloid Natural products 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims description 2
- 235000003880 Calendula Nutrition 0.000 claims description 2
- 240000001432 Calendula officinalis Species 0.000 claims description 2
- 241000218158 Clematis Species 0.000 claims description 2
- 235000011201 Ginkgo Nutrition 0.000 claims description 2
- 244000194101 Ginkgo biloba Species 0.000 claims description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 2
- 239000009429 Ginkgo biloba extract Substances 0.000 claims description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 2
- 244000141009 Hypericum perforatum Species 0.000 claims description 2
- 235000002997 Lavandula Nutrition 0.000 claims description 2
- 240000000982 Malva neglecta Species 0.000 claims description 2
- 235000000060 Malva neglecta Nutrition 0.000 claims description 2
- 240000002657 Thymus vulgaris Species 0.000 claims description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 2
- 230000001800 adrenalinergic effect Effects 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 229940011037 anethole Drugs 0.000 claims description 2
- 229940089116 arnica extract Drugs 0.000 claims description 2
- 235000019206 astragalus extract Nutrition 0.000 claims description 2
- 229940007061 capsicum extract Drugs 0.000 claims description 2
- 239000001943 capsicum frutescens fruit extract Substances 0.000 claims description 2
- 229940059958 centella asiatica extract Drugs 0.000 claims description 2
- 229960000633 dextran sulfate Drugs 0.000 claims description 2
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims description 2
- 229940068052 ginkgo biloba extract Drugs 0.000 claims description 2
- 235000020721 horse chestnut extract Nutrition 0.000 claims description 2
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 claims description 2
- 235000020748 rosemary extract Nutrition 0.000 claims description 2
- 229940092258 rosemary extract Drugs 0.000 claims description 2
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 2
- 229930182490 saponin Natural products 0.000 claims description 2
- 235000017709 saponins Nutrition 0.000 claims description 2
- 150000007949 saponins Chemical class 0.000 claims description 2
- 239000001585 thymus vulgaris Substances 0.000 claims description 2
- 239000008513 turmeric extract Substances 0.000 claims description 2
- 229940052016 turmeric extract Drugs 0.000 claims description 2
- 235000020240 turmeric extract Nutrition 0.000 claims description 2
- 244000170916 Paeonia officinalis Species 0.000 claims 3
- 244000247747 Coptis groenlandica Species 0.000 claims 1
- 235000002991 Coptis groenlandica Nutrition 0.000 claims 1
- 241000195955 Equisetum hyemale Species 0.000 claims 1
- 240000003889 Piper guineense Species 0.000 claims 1
- 241000737257 Pteris <genus> Species 0.000 claims 1
- 244000269722 Thea sinensis Species 0.000 claims 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract description 3
- 244000018633 Prunus armeniaca Species 0.000 abstract description 3
- 239000002269 analeptic agent Substances 0.000 abstract 2
- 241000748223 Alisma Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 235000011446 Amygdalus persica Nutrition 0.000 abstract 1
- 244000080208 Canella winterana Species 0.000 abstract 1
- 235000008499 Canella winterana Nutrition 0.000 abstract 1
- 241000533367 Cnidium officinale Species 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 244000171085 Polyporus umbellatus Species 0.000 abstract 1
- 235000004837 Polyporus umbellatus Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 241000951376 Schizonepeta tenuifolia Species 0.000 abstract 1
- 229940017545 cinnamon bark Drugs 0.000 abstract 1
- -1 Chlorprenaline Chemical compound 0.000 description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 52
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 49
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- 239000003921 oil Substances 0.000 description 26
- 235000019198 oils Nutrition 0.000 description 26
- 235000014113 dietary fatty acids Nutrition 0.000 description 24
- 239000000194 fatty acid Substances 0.000 description 24
- 229930195729 fatty acid Natural products 0.000 description 24
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 23
- 230000000052 comparative effect Effects 0.000 description 22
- 235000011187 glycerol Nutrition 0.000 description 21
- 241000196324 Embryophyta Species 0.000 description 20
- 150000003839 salts Chemical class 0.000 description 20
- 239000008213 purified water Substances 0.000 description 18
- 235000013399 edible fruits Nutrition 0.000 description 16
- 239000004166 Lanolin Substances 0.000 description 15
- 235000019388 lanolin Nutrition 0.000 description 15
- 229940039717 lanolin Drugs 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 239000000843 powder Substances 0.000 description 14
- 239000004359 castor oil Substances 0.000 description 13
- 235000019438 castor oil Nutrition 0.000 description 13
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- 150000005846 sugar alcohols Polymers 0.000 description 12
- 229940058015 1,3-butylene glycol Drugs 0.000 description 11
- 244000203593 Piper nigrum Species 0.000 description 11
- 235000019437 butane-1,3-diol Nutrition 0.000 description 11
- 239000000469 ethanolic extract Substances 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 10
- 239000011259 mixed solution Substances 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 241000736199 Paeonia Species 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 239000008346 aqueous phase Substances 0.000 description 9
- 239000003960 organic solvent Substances 0.000 description 9
- 229910052708 sodium Inorganic materials 0.000 description 9
- 235000015424 sodium Nutrition 0.000 description 9
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 9
- 244000183685 Citrus aurantium Species 0.000 description 8
- 235000007716 Citrus aurantium Nutrition 0.000 description 8
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 229920002125 Sokalan® Polymers 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- 210000000577 adipose tissue Anatomy 0.000 description 7
- 239000000306 component Substances 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 7
- 239000001993 wax Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 241000722363 Piper Species 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical group [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- 239000006096 absorbing agent Substances 0.000 description 5
- 210000001789 adipocyte Anatomy 0.000 description 5
- 235000013871 bee wax Nutrition 0.000 description 5
- 239000012166 beeswax Substances 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 5
- 235000019864 coconut oil Nutrition 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229940041616 menthol Drugs 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- 108010021724 tonin Proteins 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 4
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 244000276331 Citrus maxima Species 0.000 description 4
- 235000017788 Cydonia oblonga Nutrition 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 241001093501 Rutaceae Species 0.000 description 4
- 241000133134 Saussurea Species 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- 229960001948 caffeine Drugs 0.000 description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 4
- 229960000846 camphor Drugs 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- 229940105902 mint extract Drugs 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 229960002748 norepinephrine Drugs 0.000 description 4
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 4
- 229940055577 oleyl alcohol Drugs 0.000 description 4
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 229940042585 tocopherol acetate Drugs 0.000 description 4
- 229960004418 trolamine Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 240000000724 Berberis vulgaris Species 0.000 description 3
- 235000016068 Berberis vulgaris Nutrition 0.000 description 3
- 240000007124 Brassica oleracea Species 0.000 description 3
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 3
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 3
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 3
- 102000011632 Caseins Human genes 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- 241000951471 Citrus junos Species 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- 241001672694 Citrus reticulata Species 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- 229920000161 Locust bean gum Polymers 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- 244000184734 Pyrus japonica Species 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 241001122767 Theaceae Species 0.000 description 3
- 229940022663 acetate Drugs 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000013614 black pepper Nutrition 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010420 locust bean gum Nutrition 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- 239000002184 metal Chemical class 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 239000001593 sorbitan monooleate Substances 0.000 description 3
- 229940035049 sorbitan monooleate Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 239000003021 water soluble solvent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- QUNWUDVFRNGTCO-UHFFFAOYSA-N 1,7-dimethylxanthine Chemical compound N1C(=O)N(C)C(=O)C2=C1N=CN2C QUNWUDVFRNGTCO-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- XKJMBINCVNINCA-UHFFFAOYSA-N Alfalone Chemical compound CON(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XKJMBINCVNINCA-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 241000729173 Cirsium japonicum Species 0.000 description 2
- 241000548268 Citrus deliciosa Species 0.000 description 2
- 235000001759 Citrus maxima Nutrition 0.000 description 2
- 241000555678 Citrus unshiu Species 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 241000037740 Coptis chinensis Species 0.000 description 2
- 241000218203 Coptis japonica Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- JRWZLRBJNMZMFE-UHFFFAOYSA-N Dobutamine Chemical compound C=1C=C(O)C(O)=CC=1CCNC(C)CCC1=CC=C(O)C=C1 JRWZLRBJNMZMFE-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 241001079251 Euodia Species 0.000 description 2
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 229920000569 Gum karaya Polymers 0.000 description 2
- 241001316290 Gypsophila Species 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 244000115721 Pennisetum typhoides Species 0.000 description 2
- 235000007195 Pennisetum typhoides Nutrition 0.000 description 2
- 241000721490 Peperomia Species 0.000 description 2
- 241000972672 Phellodendron Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 235000008515 Setaria glauca Nutrition 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000934878 Sterculia Species 0.000 description 2
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241001222097 Xenocypris argentea Species 0.000 description 2
- BLGXFZZNTVWLAY-CCZXDCJGSA-N Yohimbine Natural products C1=CC=C2C(CCN3C[C@@H]4CC[C@@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-CCZXDCJGSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000000305 astragalus gummifer gum Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 2
- 229940093265 berberine Drugs 0.000 description 2
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 2
- 150000003836 berberines Chemical class 0.000 description 2
- BLGXFZZNTVWLAY-UHFFFAOYSA-N beta-Yohimbin Natural products C1=CC=C2C(CCN3CC4CCC(O)C(C4CC33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid Chemical class OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 239000010630 cinnamon oil Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229960001089 dobutamine Drugs 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 2
- 229960004943 ergotamine Drugs 0.000 description 2
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 239000010475 evening primrose oil Substances 0.000 description 2
- 229940089020 evening primrose oil Drugs 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- 229940012356 eye drops Drugs 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 2
- 229910000271 hectorite Inorganic materials 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229940039009 isoproterenol Drugs 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000000453 juniperus communis l. leaf oil Substances 0.000 description 2
- 235000010494 karaya gum Nutrition 0.000 description 2
- 239000000231 karaya gum Substances 0.000 description 2
- 229940039371 karaya gum Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 230000002366 lipolytic effect Effects 0.000 description 2
- 229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000012860 organic pigment Substances 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical compound OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 description 2
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 description 2
- 229960001999 phentolamine Drugs 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 229910052628 phlogopite Inorganic materials 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 235000019173 retinyl acetate Nutrition 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000019719 rose oil Nutrition 0.000 description 2
- 239000010666 rose oil Substances 0.000 description 2
- 229960002052 salbutamol Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- BXOCHUWSGYYSFW-HVWOQQCMSA-N spilanthol Chemical compound C\C=C\C=C/CC\C=C\C(=O)NCC(C)C BXOCHUWSGYYSFW-HVWOQQCMSA-N 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 2
- 229960000317 yohimbine Drugs 0.000 description 2
- AADVZSXPNRLYLV-UHFFFAOYSA-N yohimbine carboxylic acid Natural products C1=CC=C2C(CCN3CC4CCC(C(C4CC33)C(O)=O)O)=C3NC2=C1 AADVZSXPNRLYLV-UHFFFAOYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- UHSXRTHJCJGEKG-UQKRIMTDSA-N (1s)-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium-6,7-diol;chloride Chemical compound Cl.COC1=C(OC)C(OC)=CC(C[C@H]2C3=CC(O)=C(O)C=C3CCN2)=C1 UHSXRTHJCJGEKG-UQKRIMTDSA-N 0.000 description 1
- VRWOEFJNMPHSTD-UHFFFAOYSA-N (2-octoxyphenyl)-phenylmethanone Chemical compound CCCCCCCCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 VRWOEFJNMPHSTD-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- QHZUABXEBRGBLP-LKWYKXIFSA-N (6aR,9R,10aR)-N-[(2R,4R,9aS,9bR)-4-benzyl-9b-hydroxy-3,5-dioxo-2-propan-2-yl-3a,4,7,8,9,9a-hexahydrofuro[3,2-g]indolizin-2-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide (6aR,9R,10aR)-N-[(2R,4R,9aS,9bR)-9b-hydroxy-3,5-dioxo-2,4-di(propan-2-yl)-3a,4,7,8,9,9a-hexahydrofuro[3,2-g]indolizin-2-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide (6aR,10aR)-N-[(2S,4S,9bS)-9b-hydroxy-4-(2-methylpropyl)-3,5-dioxo-2-propan-2-yl-3a,4,7,8,9,9a-hexahydrofuro[3,2-g]indolizin-2-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide methanesulfonic acid Chemical compound CS(O)(=O)=O.CS(O)(=O)=O.CS(O)(=O)=O.C1=CC([C@H]2C[C@H](CN(C)[C@@H]2C2)C(=O)N[C@]3(C(=O)C4[C@H](C(N5CCC[C@H]5[C@]4(O)O3)=O)C(C)C)C(C)C)=C3C2=CNC3=C1.C1=CC([C@H]2CC(CN(C)[C@@H]2C2)C(=O)N[C@@]3(C(=O)C4[C@@H](C(N5CCCC5[C@@]4(O)O3)=O)CC(C)C)C(C)C)=C3C2=CNC3=C1.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](C(C21)=O)(NC(=O)[C@H]1CN(C)[C@H]2[C@@H](C=3C=CC=C4NC=C(C=34)C2)C1)C(C)C)C1=CC=CC=C1 QHZUABXEBRGBLP-LKWYKXIFSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- CWLGEPSKQDNHIO-JOBJLJCHSA-N (e)-n-[(e)-benzylideneamino]-1-phenylmethanimine Chemical compound C=1C=CC=CC=1/C=N/N=C/C1=CC=CC=C1 CWLGEPSKQDNHIO-JOBJLJCHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- DXMNMEWATKSWOT-UHFFFAOYSA-N 1-[2,3-di(nonyl)phenoxy]-2,3-di(nonyl)benzene Chemical compound CCCCCCCCCC1=CC=CC(OC=2C(=C(CCCCCCCCC)C=CC=2)CCCCCCCCC)=C1CCCCCCCCC DXMNMEWATKSWOT-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- ZXNAIPHYBVMMPY-KTKRTIGZSA-N 1-erucoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCC(O)CO ZXNAIPHYBVMMPY-KTKRTIGZSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- IFBDFMPSOCGRKA-UHFFFAOYSA-N 1-octadecoxyoctadecane;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC IFBDFMPSOCGRKA-UHFFFAOYSA-N 0.000 description 1
- JWKSQNWLEIABLH-UHFFFAOYSA-N 1-octan-2-yloxydodecane Chemical compound CCCCCCCCCCCCOC(C)CCCCCC JWKSQNWLEIABLH-UHFFFAOYSA-N 0.000 description 1
- QQXJNLYVPPBERR-UHFFFAOYSA-N 1-phenyldecan-1-one Chemical compound CCCCCCCCCC(=O)C1=CC=CC=C1 QQXJNLYVPPBERR-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- GQQNRZHWHWHOLI-UHFFFAOYSA-N 11-(2-decyltetradecoxymethyl)tricosane Chemical compound CCCCCCCCCCCCC(CCCCCCCCCC)COCC(CCCCCCCCCC)CCCCCCCCCCCC GQQNRZHWHWHOLI-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- AHVICBBMBPISNG-UHFFFAOYSA-N 2,2,3-trihexyl-3-propylnonanoic acid Chemical compound CCCCCCC(CCC)(CCCCCC)C(CCCCCC)(CCCCCC)C(=O)O AHVICBBMBPISNG-UHFFFAOYSA-N 0.000 description 1
- FUTGDWNFCMWSJT-UHFFFAOYSA-N 2,3-bis(14-methylpentadecanoyloxy)propyl 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C FUTGDWNFCMWSJT-UHFFFAOYSA-N 0.000 description 1
- HBOQXIRUPVQLKX-UHFFFAOYSA-N 2,3-di(octadeca-9,12-dienoyloxy)propyl octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC HBOQXIRUPVQLKX-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- MXVBVDSNBADJOC-UHFFFAOYSA-N 2-(4,5-dihydroimidazol-1-yl)-4-hydroxybutanoic acid;sodium Chemical compound [Na].OCCC(C(O)=O)N1CCN=C1 MXVBVDSNBADJOC-UHFFFAOYSA-N 0.000 description 1
- GOHZKUSWWGUUNR-UHFFFAOYSA-N 2-(4,5-dihydroimidazol-1-yl)ethanol Chemical compound OCCN1CCN=C1 GOHZKUSWWGUUNR-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- GNCOVOVCHIHPHP-UHFFFAOYSA-N 2-[[4-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-3-chlorophenyl]-2-chlorophenyl]diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC(C(=C1)Cl)=CC=C1C(C=C1Cl)=CC=C1N=NC(C(C)=O)C(=O)NC1=CC=CC=C1 GNCOVOVCHIHPHP-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- CAYHVMBQBLYQMT-UHFFFAOYSA-N 2-decyltetradecan-1-ol Chemical compound CCCCCCCCCCCCC(CO)CCCCCCCCCC CAYHVMBQBLYQMT-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- CKGQJOFAVYEVFG-KXQOOQHDSA-N 2-fluoro-4-[[(1R)-6-[2-[4-[1-(4-methoxyphenyl)-5-methyl-6-oxopyridazin-3-yl]triazol-1-yl]ethoxy]-1-methyl-1-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,4-dihydro-2H-isoquinolin-7-yl]oxy]benzoic acid Chemical compound COc1ccc(cc1)-n1nc(cc(C)c1=O)-c1cn(CCOc2cc3CCN[C@](C)(CC(=O)Nc4nccs4)c3cc2Oc2ccc(C(O)=O)c(F)c2)nn1 CKGQJOFAVYEVFG-KXQOOQHDSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- SEQOYYYZFNJQSV-UHFFFAOYSA-N 2-oxo-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound C1=C(C#N)C(=O)NC=C1C1=CC=NC=C1 SEQOYYYZFNJQSV-UHFFFAOYSA-N 0.000 description 1
- JQVJXOJHWJIKSQ-UHFFFAOYSA-N 2-oxo-5-pyridin-4-yl-1h-pyridine-3-carboxamide Chemical compound N1C(=O)C(C(=O)N)=CC(C=2C=CN=CC=2)=C1 JQVJXOJHWJIKSQ-UHFFFAOYSA-N 0.000 description 1
- OTEUSOIVNQMATD-UHFFFAOYSA-N 2-sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O.OC(=O)CC(C(O)=O)S(O)(=O)=O OTEUSOIVNQMATD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- DMICIZVPSKKBDO-UHFFFAOYSA-N 3-methylidenepiperidine Chemical compound C=C1CCCNC1 DMICIZVPSKKBDO-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- WMNORUTYNGVDKW-UHFFFAOYSA-N 4-ethyl-2-[(4-methoxyphenyl)methylidene]octanoic acid;octyl 3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=C(OC)C=C1.CCCCC(CC)CC(C(O)=O)=CC1=CC=C(OC)C=C1 WMNORUTYNGVDKW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 1
- JEDJMKTVUPSHFW-ABAIWWIYSA-L 5-[(2r)-2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate Chemical compound C1([C@@H](O)CN[C@@H](CC=2C=C3OC(OC3=CC=2)(C([O-])=O)C([O-])=O)C)=CC=CC(Cl)=C1 JEDJMKTVUPSHFW-ABAIWWIYSA-L 0.000 description 1
- JOKBLKCZHGIRNO-UHFFFAOYSA-N 5-benzoyl-2-hydroxybenzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC(C(=O)C=2C=CC=CC=2)=C1 JOKBLKCZHGIRNO-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- FEIQOMCWGDNMHM-UHFFFAOYSA-N 5-phenylpenta-2,4-dienoic acid Chemical compound OC(=O)C=CC=CC1=CC=CC=C1 FEIQOMCWGDNMHM-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- WTFUTSCZYYCBAY-SXBRIOAWSA-N 6-[(E)-C-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-N-hydroxycarbonimidoyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C/C(=N/O)/C1=CC2=C(NC(O2)=O)C=C1 WTFUTSCZYYCBAY-SXBRIOAWSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- KYHQZNGJUGFTGR-LURJTMIESA-N 7-[(2s)-2-hydroxypropyl]-1,3-dimethylpurine-2,6-dione Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C[C@@H](O)C KYHQZNGJUGFTGR-LURJTMIESA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000722942 Acanthus montanus Species 0.000 description 1
- 241001143500 Aceraceae Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001343369 Aegle <moth> Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 235000001270 Allium sibiricum Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 240000000058 Argemone mexicana Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000288673 Chiroptera Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000172828 Cirsium kamtschaticum Species 0.000 description 1
- 241001431975 Cirsium nipponicum Species 0.000 description 1
- 244000226368 Cirsium oleraceum Species 0.000 description 1
- 241000172880 Cirsium pendulum Species 0.000 description 1
- 241000606389 Cirsium purpuratum Species 0.000 description 1
- 241000172878 Cirsium yezoense Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 244000175448 Citrus madurensis Species 0.000 description 1
- 235000001938 Citrus medica Nutrition 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 241001561395 Citrus natsudaidai Species 0.000 description 1
- 235000009088 Citrus pyriformis Nutrition 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 235000010205 Cola acuminata Nutrition 0.000 description 1
- 244000228088 Cola acuminata Species 0.000 description 1
- 235000015438 Cola nitida Nutrition 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- 241000272203 Columba Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 240000003086 Cynanchum laeve Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 235000014866 Dictamnus albus Nutrition 0.000 description 1
- 244000182625 Dictamnus albus Species 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241001453700 Echinops <angiosperm> Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 241001658031 Eris Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 235000017317 Fortunella Nutrition 0.000 description 1
- 235000017316 Fortunella japonica Nutrition 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 244000197258 Hibiscus schizopetalus Species 0.000 description 1
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 241001111240 Jateorhiza Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000019510 Long pepper Nutrition 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000245214 Mentha canadensis Species 0.000 description 1
- 235000016278 Mentha canadensis Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 241001477931 Mythimna unipuncta Species 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- NXMKHXUMUTXJAV-UHFFFAOYSA-N OCC(O)CO.C(CCCCCCCC=C/CCCCCCCC)(=O)O.OCC(O)CO.C(CCCCCCCC=C/CCCCCCCC)(=O)O.C(CCCCCCCC=C/CCCCCCCC)(=O)O Chemical compound OCC(O)CO.C(CCCCCCCC=C/CCCCCCCC)(=O)O.OCC(O)CO.C(CCCCCCCC=C/CCCCCCCC)(=O)O.C(CCCCCCCC=C/CCCCCCCC)(=O)O NXMKHXUMUTXJAV-UHFFFAOYSA-N 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241001400033 Omia Species 0.000 description 1
- 241001079008 Orixa japonica Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 241001537694 Parupeneus barberinus Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001248016 Peperomia caperata Species 0.000 description 1
- 241001055065 Peperomia incana Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000008681 Phellinus linteus extract Substances 0.000 description 1
- QZVCTJOXCFMACW-UHFFFAOYSA-N Phenoxybenzamine Chemical compound C=1C=CC=CC=1CN(CCCl)C(C)COC1=CC=CC=C1 QZVCTJOXCFMACW-UHFFFAOYSA-N 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 241001299781 Pilocarpus pennatifolius Species 0.000 description 1
- 241000490567 Pinctada Species 0.000 description 1
- 244000039543 Pinus insularis Species 0.000 description 1
- 235000008180 Piper betle Nutrition 0.000 description 1
- 240000008154 Piper betle Species 0.000 description 1
- 240000003731 Piper cubeba Species 0.000 description 1
- 240000003455 Piper longum Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ADUKCCWBEDSMEB-NSHDSACASA-N Prenalterol Chemical compound CC(C)NC[C@H](O)COC1=CC=C(O)C=C1 ADUKCCWBEDSMEB-NSHDSACASA-N 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000003976 Ruta Nutrition 0.000 description 1
- 240000005746 Ruta graveolens Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 241000199064 Saussurea brachycephala Species 0.000 description 1
- 241000199085 Saussurea gracilis Species 0.000 description 1
- 241001373813 Saussurea japonica Species 0.000 description 1
- 241000198902 Saussurea nikoensis Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 241000516841 Scomberomorus sinensis Species 0.000 description 1
- 241000276699 Seriola Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000133042 Synurus Species 0.000 description 1
- 241001282577 Synurus palmatopinnatifidus Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 241000375392 Tana Species 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- BXOCHUWSGYYSFW-UHFFFAOYSA-N all-trans spilanthol Natural products CC=CC=CCCC=CC(=O)NCC(C)C BXOCHUWSGYYSFW-UHFFFAOYSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 230000006229 amino acid addition Effects 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- RNLQIBCLLYYYFJ-UHFFFAOYSA-N amrinone Chemical compound N1C(=O)C(N)=CC(C=2C=CN=CC=2)=C1 RNLQIBCLLYYYFJ-UHFFFAOYSA-N 0.000 description 1
- 229960002105 amrinone Drugs 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000001053 badasse Nutrition 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229910052916 barium silicate Inorganic materials 0.000 description 1
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical compound [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003918 blood extract Substances 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 229950011520 butopamine Drugs 0.000 description 1
- FWRAZOHAPWEJFM-UHFFFAOYSA-N butyl 3-(3,4,5-trimethoxyphenyl)prop-2-enoate Chemical compound CCCCOC(=O)C=CC1=CC(OC)=C(OC)C(OC)=C1 FWRAZOHAPWEJFM-UHFFFAOYSA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- HRBZRZSCMANEHQ-UHFFFAOYSA-L calcium;hexadecanoate Chemical compound [Ca+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O HRBZRZSCMANEHQ-UHFFFAOYSA-L 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000010624 camphor oil Substances 0.000 description 1
- 229960000411 camphor oil Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000010227 chenpi Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- 229910000152 cobalt phosphate Inorganic materials 0.000 description 1
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 1
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- HESHRHUZIWVEAJ-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C)C1=CC=CC=C1 HESHRHUZIWVEAJ-JGRZULCMSA-N 0.000 description 1
- 229960004704 dihydroergotamine Drugs 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 229960002819 diprophylline Drugs 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- KSCFJBIXMNOVSH-UHFFFAOYSA-N dyphylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CC(O)CO)C=N2 KSCFJBIXMNOVSH-UHFFFAOYSA-N 0.000 description 1
- XLMJRFCCCWFQRE-SJRQCXNHSA-N ecboline Chemical compound C([C@H]1[C@]2(O)O3)CCN1C(=O)CN2C(=O)[C@]3(C(C)C)NC(=O)[C@@H](CN(C)[C@@H]1C2)C=C1C1=C3C2=CNC3=CC=C1 XLMJRFCCCWFQRE-SJRQCXNHSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 229960001022 fenoterol Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 229940077441 fluorapatite Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- OXLZNBCNGJWPRV-UHFFFAOYSA-N hexoprenaline Chemical compound C=1C=C(O)C(O)=CC=1C(O)CNCCCCCCNCC(O)C1=CC=C(O)C(O)=C1 OXLZNBCNGJWPRV-UHFFFAOYSA-N 0.000 description 1
- 229960000708 hexoprenaline Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- MSVZUEGLXXVUJS-UHFFFAOYSA-N hydron;n-(2-piperidin-1-ylethyl)-n-(pyridin-2-ylmethyl)aniline;chloride Chemical compound Cl.C=1C=CC=NC=1CN(C=1C=CC=CC=1)CCN1CCCCC1 MSVZUEGLXXVUJS-UHFFFAOYSA-N 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 229960005436 inositol nicotinate Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 244000056931 lavandin Species 0.000 description 1
- 235000009606 lavandin Nutrition 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 239000003915 liquefied petroleum gas Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229910001947 lithium oxide Inorganic materials 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- LMOINURANNBYCM-UHFFFAOYSA-N metaproterenol Chemical compound CC(C)NCC(O)C1=CC(O)=CC(O)=C1 LMOINURANNBYCM-UHFFFAOYSA-N 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- PABHEXWDYRTPBQ-UHFFFAOYSA-N methyl 3-[2,5-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC(C(C)C)=CC=C1C(C)C PABHEXWDYRTPBQ-UHFFFAOYSA-N 0.000 description 1
- LZULAZTXJLWELL-UHFFFAOYSA-N methyl hex-5-ynoate Chemical compound COC(=O)CCCC#C LZULAZTXJLWELL-UHFFFAOYSA-N 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 229940059453 millet extract Drugs 0.000 description 1
- PZRHRDRVRGEVNW-UHFFFAOYSA-N milrinone Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1C PZRHRDRVRGEVNW-UHFFFAOYSA-N 0.000 description 1
- 229960003574 milrinone Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- MFZCIDXOLLEMOO-GYSGTQPESA-N myo-inositol hexanicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- FWRBVROZVUCLNY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O FWRBVROZVUCLNY-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 229960002657 orciprenaline Drugs 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- RLANKEDHRWMNRO-UHFFFAOYSA-M oxtriphylline Chemical compound C[N+](C)(C)CCO.O=C1N(C)C(=O)N(C)C2=C1[N-]C=N2 RLANKEDHRWMNRO-UHFFFAOYSA-M 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- ZNSSPLQZSUWFJT-UHFFFAOYSA-N pentyl 4-hydroxybenzoate Chemical compound CCCCCOC(=O)C1=CC=C(O)C=C1 ZNSSPLQZSUWFJT-UHFFFAOYSA-N 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 229960003418 phenoxybenzamine Drugs 0.000 description 1
- 125000000914 phenoxymethylpenicillanyl group Chemical group CC1(S[C@H]2N([C@H]1C(=O)*)C([C@H]2NC(COC2=CC=CC=C2)=O)=O)C 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 239000001931 piper nigrum l. white Substances 0.000 description 1
- LYKMMUBOEFYJQG-UHFFFAOYSA-N piperoxan Chemical compound C1OC2=CC=CC=C2OC1CN1CCCCC1 LYKMMUBOEFYJQG-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 229960004358 prenalterol Drugs 0.000 description 1
- 229960002789 procaterol hydrochloride Drugs 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229960004767 proxyphylline Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229930195215 pungen Natural products 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940043131 pyroglutamate Drugs 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- YJQZYXCXBBCEAQ-UHFFFAOYSA-N ractopamine Chemical compound C=1C=C(O)C=CC=1C(O)CNC(C)CCC1=CC=C(O)C=C1 YJQZYXCXBBCEAQ-UHFFFAOYSA-N 0.000 description 1
- WPPDXAHGCGPUPK-UHFFFAOYSA-N red 2 Chemical compound C1=CC=CC=C1C(C1=CC=CC=C11)=C(C=2C=3C4=CC=C5C6=CC=C7C8=C(C=9C=CC=CC=9)C9=CC=CC=C9C(C=9C=CC=CC=9)=C8C8=CC=C(C6=C87)C(C=35)=CC=2)C4=C1C1=CC=CC=C1 WPPDXAHGCGPUPK-UHFFFAOYSA-N 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000005806 ruta Nutrition 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000010675 spruce oil Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 229940071136 stearoyl glutamate Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229910052917 strontium silicate Inorganic materials 0.000 description 1
- QSQXISIULMTHLV-UHFFFAOYSA-N strontium;dioxido(oxo)silane Chemical compound [Sr+2].[O-][Si]([O-])=O QSQXISIULMTHLV-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 239000002383 tung oil Substances 0.000 description 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229940105125 zinc myristate Drugs 0.000 description 1
- GBFLQPIIIRJQLU-UHFFFAOYSA-L zinc;tetradecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O GBFLQPIIIRJQLU-UHFFFAOYSA-L 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は優れた脂質分解促進
作用を有する脂質分解促進剤および該脂質分解促進剤を
用いた痩身用皮膚外用剤に関する。TECHNICAL FIELD The present invention relates to a lipolysis promoter having an excellent lipolysis-promoting action, and a slimming skin external preparation using the lipolysis-promoter.
【0002】[0002]
【従来の技術および発明が解決しようとする課題】従
来、顔や体の余分な脂肪を減らし、引き締まった体を保
つために、各種運動や食事制限に加え、体内の新陳代謝
を促すようなマッサージ用ジェル、クリーム等の化粧料
を用いることが知られている。このような化粧料には、
脂肪を構成している脂肪細胞の脂質分解を促進し、痩身
効果を有しめることを目的としてカフェインのような脂
質分解促進剤が配合されている。脂肪分解を促す物質と
してはカフェインの他、植物抽出液として、茶抽出物、
コラ抽出物等が知られているが、いずれも充分な効果を
有するものではなく、より一層効果の高い脂質分解促進
物質の開発が望まれていた。2. Description of the Related Art In the past, in order to reduce excess fat on the face and body and maintain a lean body, in addition to various exercises and dietary restrictions, massage for promoting metabolism in the body It is known to use cosmetics such as gel and cream. Such cosmetics include
A lipolysis-promoting agent such as caffeine has been added for the purpose of promoting the lipolysis of fat cells constituting fat and having a slimming effect. In addition to caffeine as a substance that promotes lipolysis, as a plant extract, tea extract,
Although kola extract and the like are known, none of them have sufficient effects, and there has been a demand for the development of a more effective lipid decomposition promoting substance.
【0003】したがって本発明の目的は、脂肪細胞の脂
肪分解を促進し、優れた痩身効果を与える脂質分解促進
剤を提供することにある。Therefore, an object of the present invention is to provide a lipolysis promoter which promotes lipolysis of adipocytes and gives an excellent slimming effect.
【0004】[0004]
【課題を解決するための手段】本発明者らは、脂肪細胞
の脂質分解を促進するものはないかと鋭意研究した結
果、キョウニン、シャクヤク、トウニン、ブクリョウ、
キキョウ、ケイカイ、ケイシ、チョレイ、ビャクジュ
ツ、ジオウ、センキュウ、タイソウ、トウキ、バクモン
ドウ、ハッカ、タクシャ、ボウフウおよびサンシュユの
うちの一種または二種以上から抽出された抽出物にその
効果があること、およびこの抽出物と、他の特定の成分
とを組み合わせると脂質分解促進効果および使用効果が
さらに高まることを見い出し、本発明を完成するに至っ
た。[Means for Solving the Problems] The inventors of the present invention have conducted extensive studies as to whether or not there is a substance that promotes lipolysis of adipocytes, and as a result, kyounin, peony, tonin, bukuro,
Effectiveness of extracts from one or more of kyokyou, keikai, keishi, chorei, juniper, zelkova, zelkova, pearl millet, touki, bakumondou, mint, takusha, boufu and sanshuyu, and this It has been found that a combination of the extract and other specific components further enhances the lipolysis promoting effect and the use effect, and has completed the present invention.
【0005】すなわち本発明は、キョウニン、シャクヤ
ク、トウニン、ブクリョウ、キキョウ、ケイカイ、ケイ
シ、チョレイ、ビャクジュツ、ジオウ、センキュウ、タ
イソウ、トウキ、バクモンドウ、ハッカ、タクシャ、ボ
ウフウおよびサンシュユのうちの一種または二種以上か
ら抽出された抽出物よりなることを特徴とする脂質分解
促進剤、および前記抽出物を有効成分として配合するこ
とを特徴とする痩身用皮膚外用剤である。That is, the present invention relates to one or two kinds of Kyounin, Peonies, Tounin, Bukuryou, Kyoukyo, Keikai, Keishi, Chorei, Jakujutsu, Jio, Senkyu, Taiso, Touki, Bakumondou, Hakka, Takusha, Boufu and Sanshuyu. A lipid decomposition promoter comprising the extract extracted as described above, and a slimming skin external preparation containing the extract as an active ingredient.
【0006】また本発明によれば、キョウニン、シャク
ヤク、トウニン、ブクリョウ、キキョウ、ケイカイ、ケ
イシ、チョレイ、ビャクジュツ、ジオウ、センキュウ、
タイソウ、トウキ、バクモンドウ、ハッカ、タクシャ、
ボウフウおよびサンシュユのうちの一種または二種以上
から抽出された抽出物と、他の特定の成分とを有効成分
として配合する痩身用皮膚外用剤が提供される。Further, according to the present invention, Kyounin, peony, Tounin, Bukyou, Kyoukyo, Keikai, Keishi, Chorei, juniper, zelkova, senkyu,
Taiso, Touki, Bakumondou, peppermint, Takusha,
There is provided a slimming skin external preparation, which comprises an extract extracted from one or more of Bofu and Sanshuyu as an active ingredient and other specific ingredients.
【0007】以下、本発明の構成について詳述する。本
発明で用いられる植物抽出物は、花、茎、果実、種子、
根、全草等が用いられる。抽出方法は特に限定されるも
のではなく、例えば水、アルコール等の親水性有機溶
剤、あるいはそれらの混合液、またはグリセリン、1,
3−ブチレングリコール等の多価アルコール、あるいは
水と多価アルコールとの混合液により抽出される。The structure of the present invention will be described in detail below. The plant extract used in the present invention includes flowers, stems, fruits, seeds,
Roots, whole plants, etc. are used. The extraction method is not particularly limited, for example, water, a hydrophilic organic solvent such as alcohol, or a mixed solution thereof, or glycerin, 1,
It is extracted with a polyhydric alcohol such as 3-butylene glycol or a mixed liquid of water and a polyhydric alcohol.
【0008】皮膚外用剤中ヘの抽出物の配合量は、乾燥
物換算でそれぞれ0.001〜30.0重量%、好まし
くは0.01〜20.0重量%である。抽出物の配合量
が0.001重量%未満では十分な脂質分解効果が得ら
れない。The content of the extract in the external preparation for skin is 0.001 to 30.0% by weight, preferably 0.01 to 20.0% by weight in terms of dry matter. If the content of the extract is less than 0.001% by weight, a sufficient lipolytic effect cannot be obtained.
【0009】本発明においては、キョウニン、シャクヤ
ク、トウニン、ブクリョウ、キキョウ、ケイカイ、ケイ
シ、チョレイ、ビャクジュツ、ジオウ、センキュウ、タ
イソウ、トウキ、バクモンドウ、ハッカ、タクシャ、ボ
ウフウおよびサンシュユのうちの一種または二種以上か
ら抽出された抽出物と、他の特定の成分とを併用するこ
とにより、脂質分解促進効果はより高められる。[0009] In the present invention, one or two kinds of Kyounin, peony, Tounin, Bukyou, Kyoukyo, Keikai, Keishi, Chorei, juniper, zelkova, diorama, senkyu, tanso, touki, bakumondou, mentha, takusha, bofu and sanshuyu. The combined use of the extract extracted from the above and other specific components further enhances the lipolysis promoting effect.
【0010】かかる特定の成分としては、例えば、キサ
ンチン誘導体、シソ科ラヴァンドラ属植物抽出物、セリ
科ウイキョウ属植物抽出物、イノシット、デキストラン
硫酸、海藻抽出物、アミノ酸、エスクロシド、ミカン科
植物抽出物、βアドレナリン作用興奮薬、α2アドレナ
リン作用抑制薬、ビピリジン誘導体、コショウ科植物抽
出物、アザミ族植物抽出物、茶抽出物、オウレンエキ
ス、オウバクエキス、ベルベリン型アルカロイド、イチ
ョウ抽出物、チョウセンニンジン抽出物、タイソウエキ
ス、ツボクサエキス、ブッチャーブルームエキス、ゼニ
アオイエキス、ウコンエキス、タイムエキス、アルニカ
エキス、イチョウエキス、マロニエエキス、トウガラシ
エキス、キヅタエキス、マンネンロウ、キンセンカ、サ
ルビア、オトギリソウ、シモツケソウエキス、ショウキ
ョウ、ローズマリーエキス、アネトール、サポニン類、
スギナエキス、クレマチスエキスおよびツヅラフジ科植
物抽出物から選ばれる一種または二種以上が好ましい。Examples of the specific component include xanthine derivatives, Lavandula genus plant extracts, Apiaceae fennel plant extracts, inosit, dextran sulfate, seaweed extracts, amino acids, escrosides, citrus plant extracts, β-adrenergic stimulant, α2-adrenergic inhibitor, bipyridine derivative, pepper extract, thistle plant extract, tea extract, Coptis chinensis extract, Oataku extract, berberine-type alkaloid, Ginkgo biloba extract, Ginseng extract, Primrose extract, Centella asiatica extract, Butcher bloom extract, Mallow extract, Turmeric extract, Thyme extract, Arnica extract, Ginkgo extract, Horse chestnut extract, Capsicum extract, Ivy extract, Mannen wax, Calendula, Salvia, Hypericum perforatum. , Astragalus extract, Ginger, Rosemary extract, Anethole, Saponins,
One or more selected from horse mackerel extract, clematis extract and plant extract of Amaranthaceae are preferable.
【0011】本発明で用いられるキサンチン誘導体とし
ては、例えば、キサンチン、アミノフィリン、テオフィ
リン、コリンテオフィリン、カフェイン、テオブロミ
ン、1,7−ジメチルキサンチン、オクストリフィン、
ジプロフィリン、プロキシフィリン等が挙げられる。こ
れらは1種を単独で、または2種以上を組み合わせて用
いることができる。これらのキサンチン誘導体は、合成
または茶葉等の植物から実質的に単離されたものを使用
することができる。Examples of the xanthine derivative used in the present invention include xanthine, aminophylline, theophylline, choline theophylline, caffeine, theobromine, 1,7-dimethylxanthine, oxtrifine,
Examples include diprophylline and proxyphylline. These may be used alone or in combination of two or more. These xanthine derivatives may be synthetic or substantially isolated from plants such as tea leaves.
【0012】本発明で用いられるシソ科ラウァンドゥラ
属植物は約20種余りを含み、例えばラウァンドゥラ、
アングスティフォリア、ラベンダー、ラウァンドゥラ・
アングスティフォリア・ピレナイカ、スパイク・ラベン
ダー、ラバンジン等が挙げられる。これらの植物は、
花、茎、果実、種子、根、全草等が用いられ、好ましく
は花が用いられる。抽出方法は特に限定されるものでは
なく、例えば水、アルコール等の親水性有機溶剤、ある
いはそれらの混合液、またはグリセリン、1,3−ブチ
レングリコール等の多価アルコール、あるいは水と多価
アルコールとの混合液により抽出される。The plant of the genus Lauandra, used in the present invention, contains about 20 kinds of plants, for example, Lauandra,
Angustifolia, Lavender, Rauandra
Examples include Angustifolia Pyreneika, Spike Lavender, and Lavandin. These plants are
Flowers, stems, fruits, seeds, roots, whole plants and the like are used, and flowers are preferably used. The extraction method is not particularly limited, for example, water, a hydrophilic organic solvent such as alcohol, or a mixed solution thereof, or glycerin, a polyhydric alcohol such as 1,3-butylene glycol, or water and a polyhydric alcohol. It is extracted with a mixed solution of.
【0013】本発明で用いられるセリ科ウイキョウ属植
物は2〜3種を含み、例えばウイキョウ、イタリアウイ
キョウ等が挙げられる。これらの植物は、花、茎、果
実、種子、根、全草等が用いられ、好ましくは果実が用
いられる。抽出方法は特に限定されるものではなく、例
えば水、アルコール等の親水性有機溶剤、あるいはそれ
らの混合液、またはグリセリン、1,3−ブチレングリ
コール等の多価アルコール、あるいは水と多価アルコー
ルとの混合液により抽出される。The plant of the genus Apiaceae used in the present invention includes 2-3 species, and examples thereof include fennel and Italian fennel. As these plants, flowers, stems, fruits, seeds, roots, whole plants and the like are used, and fruits are preferably used. The extraction method is not particularly limited, for example, water, a hydrophilic organic solvent such as alcohol, or a mixed solution thereof, or glycerin, a polyhydric alcohol such as 1,3-butylene glycol, or water and a polyhydric alcohol. It is extracted with a mixed solution of.
【0014】本発明で用いられる海藻抽出物は褐藻類、
紅藻類、緑藻類の全藻から抽出されるものであり、抽出
方法は特に限定されるものではなく、例えば水、アルコ
ール等の親水性有機溶剤、あるいはそれらの混合液、ま
たはグリセリン、1,3−ブチレングリコール等の多価
アルコール、あるいは水と多価アルコールとの混合液に
より抽出される。The seaweed extract used in the present invention is a brown alga,
It is extracted from all algae of red algae and green algae, and the extraction method is not particularly limited. For example, water, a hydrophilic organic solvent such as alcohol, or a mixed solution thereof, or glycerin, 1,3- It is extracted with a polyhydric alcohol such as butylene glycol or a mixed liquid of water and a polyhydric alcohol.
【0015】本発明で用いられるミカン科植物として
は、Citrus属のウンシュウミカン(Citrus
unshiu Marcov)、オオベニミカン(C
itrus tangerina Tanaka)、コ
ベニミカン(Citrus erythrosa Ta
naka)、ミカン(Citrus aurantiu
m L subsp.nobilis Makin
o),Citrus aurantium L、ダイダ
イ(Citrus aurantium L.,va
r.daidai Makino)、マルブシュカン
(Citrus medica L)、ナツミカン(C
itrus Natsudaidai Hayat
a)、ザボン(Citrus grandis Osb
eck)、ユズ(Citrus Junos Tana
ka)、ポンカン(Citrus reticulat
a Blanco)、レモン(Citrus limo
n Burmann)、カラタチ(Citrus tr
ifoliata L)、Fortunella属のマ
ルキンカン(Fortunella japonica
swingle)、Xanthoxyum属のサンシ
ョウ(Xanthoxyum piperitum D
C.)、Evodia属のゴシュユ(Evodia r
utaecarpa Hook.fil et Tho
ms.)の他、マエグル・マルメロス(Aegle m
armelos Corr)、ブッコキノキ(Agat
hosma betulina Pill)、ハクセン
(Dictamnusalbus L)、イヌザンショ
ウ(Fragara mante churica H
onda)、コクサギ(Orixa japonica
Thunb)、キハダ(Phellodendron
amurense Rupr)、ピロカルプス・ペン
ナティフォリウス(Pilocarpus penna
tifolius Lan)、フェロデンドロン・チ
ネンセ(Phellodendron chinens
e Schneido)、ヘンルウダ(Ruta gr
aveolens L)、ミヤマキシミ(Skimmi
a japonica Thunb)等が挙げられる。
これらの中でも特に、オオベニミカン、コベニミカンが
好ましい。The Rutaceae plant used in the present invention includes the citrus genus Citrus
unshiu Marcov), Ovenimikan (C
itrus tangerina Tanaka), cobenimikan (Citrus erythrosa Ta
naka), mandarin orange (Citrus aurantiu)
m L subsp. nobilis Makin
o), Citrus aurantium L., Daidai (Citrus aurantium L., va
r. daidai Makino), Marubushkan (Citrus medica L), Natsumikan (C
itrus Natsudaidai Hayat
a), pomelo (Citrus grandis Osb)
eck), Yuzu (Citrus Junos Tana)
ka), Ponkan (Citrus reticulat)
a Blanco), lemon (Citrus limo)
n Burmann), Karatachi (Citrus tr)
ifoliata L), a Fortunella genus Malchincan (Fortunella japonica)
Swingle), Xanthoxium piperium D
C. ), The genus Evodia (Evodia r)
utaecarpa Hook. fil et Tho
ms. ), As well as Aegle m.
armelos Corr), Bukkokinoki (Agat)
hosma betulina Pill), Chinese cabbage (Dictamnus albus L), Indica Zinsho (Fragara mante churica H)
onda), European heron (Orixa japonica)
Thunb), Yellowfin (Phellodendron)
amurense Rupr, Pilocarpus penna
tifolius Lan), Phellodendron chinens
e Schneido), Henruda (Ruta gr)
aveolens L), Miyamaximi (Skimmi)
a japonica Thunb) and the like.
Among these, Obeni mandarin and Coben mandarin are especially preferable.
【0016】かかるミカン科植物としては、成熟した、
または未成熟の果実、果皮、種子、葉、葉柄、枝、根、
花等が原料として用いられるが、その中でも果実、果
皮、葉が好ましい。但し、上記ミカン科植物には、健
胃、鎮咳、駆風を目的として漢方処方に配剤され、内服
したり、外用・浴用として使用されるものに陳皮(チン
ピ)、橙皮(トウヒ)がある。陳皮は主にウンシュウミ
カン(Citrus unshiu Marcov)、
橙皮はCitrus aurantium Lまたはダ
イダイ(Citrus aurantium L.,v
ar.daidaiMakino)の成熟した果皮であ
り、これらを原料として用いた場合は、本発明の目的と
する効果は小さいので、かかる3種については未成熟な
果実または葉を用いることが好ましい。また、従来より
食用されるミカン(Citrusaurantium
L subsp.nobilis Makino)、ナ
ツミカン(Citrus Natsudaidai H
ayata)、ザボン(Citrus grandis
Osbeck)、ユズ(Citrus Junos
Tanaka)、レモン(Citrus limon
Burmann)の成熟した果肉およびサンショウ(X
anthoxyum piperitumDC.)の成
熟果実についても、本発明の目的とする効果が小さいた
め、未成熟な果実を用いるか、果皮や葉を用いることが
好ましい。The citrus plants are mature,
Or immature fruits, peels, seeds, leaves, petioles, branches, roots,
Flowers and the like are used as a raw material, and among them, fruits, peels and leaves are preferable. However, among the above Rutaceae plants, there are Chenpi and orange peel (spruce) that are used for internal use or for external use / bath, which are distributed in Kampo prescription for the purpose of stomach ache, antitussive and carminative. . The rind is mainly Citrus unshiu Marcov,
The orange peel is Citrus aurantium L. or Daidai (Citrus aurantium L., v
ar. It is a matured pericarp of daidaii Makino), and when these are used as a raw material, the effect intended by the present invention is small. Therefore, it is preferable to use immature fruits or leaves for these three species. In addition, mandarin oranges (Citrus aurantium) that have been eaten conventionally
L subsp. nobilis Makino, Citrus Natsudaidai H
ayata), pomelo (Citrus grandis
Osbeck, Yuzu (Citrus Junos)
Tanaka, lemon (Citrus limon)
Burmann) mature pulp and salmon (X
anthoxium piperium DC. With respect to the matured fruit of (1), since the effect of the present invention is small, it is preferable to use an immature fruit, or a pericarp or leaf.
【0017】本発明におけるミカン科植物は、水溶性溶
剤抽出物として使用される。溶剤抽出物としては、水ま
たは低級アルコール、ポリオール等の有機溶媒あるいは
これらの混合溶媒で抽出したものを挙げることができ、
これは適宜濃縮、精製、滅菌、乾燥等を施して便用され
る。The Rutaceae plant of the present invention is used as a water-soluble solvent extract. Examples of the solvent extract include water or lower alcohols, those extracted with an organic solvent such as polyol or a mixed solvent thereof,
This is conveniently used after being subjected to concentration, purification, sterilization, drying, etc. as appropriate.
【0018】本発明で用いられるβアドレナリン作用興
奮剤は特に限定されず、例えばイソプロテレノール、エ
ピネフリン、ノルエピネフリン、ドブタミン、ドパミ
ン、ブトパミン、サルブタモール、テルブタリン、イソ
エタリン、プロトキロール、フェノテロール、メタプロ
テレノール、クロルプレナリン、ヘキソプレナリン、ト
リメトキノール、塩酸プロカテロール、プレナルテロー
ル、フォルスコリン、ジソジウム(R,R)−5−〔2
−〔〔2−(3−クロロフェニル)−2−ヒドロキシエ
チル〕−アミノ〕プロピル〕−1,3−ベンゾジオキソ
ール−2,2−ジカルボキシレート、(R,R)−4−
〔2−({2−〔(3−クロロフェニル)−2−ヒドロ
キシエチル〕アミノ}プロピル)フェニル〕フェノキシ
酢酸、{2−ヒドロキシ−5−〔2−({2−ヒドロキ
シ−3−〔4−(1−メチル−4−トリフルオロメチ
ル)−1H−イミダゾール−2−イル〕フェノキシ}プ
ロピル)アミノ〕エトキシ}−ベンズアミドモノメタン
スルフォネート、エリスロ−DL−1−(7−メチルイ
ンダン−4−イロキシ)−3−イソプロピルアミノブタ
ン−2−オールおよびこれらの薬理的に許容される塩等
が挙げられる。薬理的に許容される塩としては、薬理的
に許容される酸付加塩、金属塩、アンモニウム塩、有機
アミン付加塩、アミノ酸付加塩等が挙げられる。本発明
においては、イソプロテレノール、ドブタミン、サルブ
タモールおよびこれらの薬理的に許容される塩からなる
群から選ばれる一種または二種以上を用いることが好ま
しく、この場合の塩としては塩酸塩や硫酸塩が好まし
い。The β-adrenergic stimulant used in the present invention is not particularly limited, and examples thereof include isoproterenol, epinephrine, norepinephrine, dobutamine, dopamine, butopamine, salbutamol, terbutaline, isoethalin, protoxylol, fenoterol, metaproterenol, Chlorprenaline, hexoprenaline, trimethoquinol, procaterol hydrochloride, prenalterol, forskolin, disodium (R, R) -5- [2
-[[2- (3-Chlorophenyl) -2-hydroxyethyl] -amino] propyl] -1,3-benzodioxole-2,2-dicarboxylate, (R, R) -4-
[2-({2-[(3-chlorophenyl) -2-hydroxyethyl] amino} propyl) phenyl] phenoxyacetic acid, {2-hydroxy-5- [2-({2-hydroxy-3- [4- ( 1-methyl-4-trifluoromethyl) -1H-imidazol-2-yl] phenoxy} propyl) amino] ethoxy} -benzamide monomethanesulfonate, erythro-DL-1- (7-methylindan-4-yloxy) ) -3-Isopropylaminobutan-2-ol and pharmacologically acceptable salts thereof. Examples of the pharmaceutically acceptable salt include pharmaceutically acceptable acid addition salts, metal salts, ammonium salts, organic amine addition salts, amino acid addition salts and the like. In the present invention, it is preferable to use one or more selected from the group consisting of isoproterenol, dobutamine, salbutamol and pharmacologically acceptable salts thereof. As the salt in this case, hydrochloride or sulfate is used. Is preferred.
【0019】本発明で用いられるα2アドレナリン作用
抑制剤は特に限定されず、例えばヨヒンビン、フェント
ラミン、フェノキシベンザミン、トラゾリン、エルゴタ
ミン、エルゴトキシン、ジヒドロエルゴタミン、エルゴ
メトリン、メチルエルゴメトリン、ジヒドロエルゴトキ
シン、ラウオルシン、ピペロキサンおよびこれらの薬理
的に許容される塩等が挙げられる。薬理的に許容される
塩としては、上記と同様のものが挙げられる。本発明に
おいては、ヨヒンビン、フェントラミン、エルゴタミン
およびこれらの薬理的に許容される塩からなる群から選
ばれる一種または二種以上を用いることが好ましく、こ
の場合の塩としてはメシル酸塩や酒石酸塩、塩酸塩が好
ましい。The α2 adrenergic action inhibitor used in the present invention is not particularly limited and includes, for example, yohimbine, phentolamine, phenoxybenzamine, trazoline, ergotamine, ergotoxin, dihydroergotamine, ergomethrin, methylergomethrin, dihydroergotoxin, lauorcin, Examples thereof include piperoxane and pharmacologically acceptable salts thereof. Examples of the pharmacologically acceptable salt include those similar to the above. In the present invention, it is preferable to use one or more selected from the group consisting of yohimbine, phentolamine, ergotamine and pharmaceutically acceptable salts thereof, and as the salt in this case, a mesylate salt or a tartrate salt, The hydrochloride salt is preferred.
【0020】本発明に用いられるビピリジン誘導体とし
ては、アムリノン、ミルリノン、5−シアノ−[3,
4’−ビピリジン]−6(1H)−オン、5−カルバミ
ル−[3,4’−ビピリジン]−6(1H)−オンおよ
びこれらの薬理的に許容される塩等が挙げられる。The bipyridine derivative used in the present invention includes amrinone, milrinone, 5-cyano- [3,
4′-bipyridin] -6 (1H) -one, 5-carbamyl- [3,4′-bipyridin] -6 (1H) -one, and pharmacologically acceptable salts of these.
【0021】本発明で用いられるコショウ科植物として
は、コショウ(PiPer nigrum L.)、ヒ
ハツ(Piper longum L.)、サダソウ
(Peperomia japonica Makin
o)、シマゴショウ(PePeromia bunin
simensis Makino)、チジミバシマアオ
イソウ(PePeromia caperata Ru
iz.et Pav.)、ワタゲアオイソウ(PePe
romia incana A.Dietr)、シロシ
マアオイソウ(Peperomia magnolif
olia A.Dietr.var variegat
a R.et P.)、ササバアオイソウ(Peper
omia puteolata Trel.)、シマア
オイソウ(Peperomia sandersii
C.DC.var.argyreia Baile
y)、キンマ(Piper betele L.)、ク
ベバ(Piper cubeba L.)、カバ(Pi
per methysticum Forst)、ジャ
ワナガゴショウ(Piper retrofractu
m Vahl)、ナントウゴショウ(Piper au
rantiacumWall.var hupehen
se C.DC.)、フウトウカズラ(Piper k
adzura Ohwi)、ピパー べーメリエフォリ
ウム ウォール(Piper boehmeriaef
olium Wall)、ピパーハイナネーゼ ヘムル
(Piper hainanense Hemsl)、
ピパーハウセイ マキシム.(Piper hauce
i Maxim.)、ピパーサーメントサム ロクス
(Piper sarmentosum Roxb)等
が挙げられる。これらの中でも特に、ヨショウ、ヒハツ
が好ましい。Pepperaceae plants used in the present invention include pepper (Piper nigrum L.), hihatsu (Piper longum L.), and Sadasou (Peperomia japonica Makin).
o), sesame show (PePeromia bunin)
siemesis Makino), Peperomia caperata Ru
iz. et Pav. ), Japanese armyworm (PePe
romia incana A. Dietr), P. perennia magnolif
olia A. Dietr. var varyegat
a R.A. et P. et al. ), Chinese mackerel (Pepper)
omia puteolata Trel. ), Peaomia sandersii
C. DC. var. argyrea Baile
y), betel (Pipere betele L.), cubbeba (Piper cubebe L.), hippo (Pi)
per mesosticum Forst, Javan Goatfish (Piper retrofructu)
m Vahl), Nantogogosho (Piper au)
rantiacum Wall. var hupehen
se C. DC. ), Amberjack, Piper k
Adzura Ohwi), Piper Boehmérief Wall
olium Wall), Piper Hainanese Hemml,
Pippa Hausie Maxim. (Piper hauce
i Maxim. ), And pipermentomentum Roxb. Among these, yosho and hihatsu are particularly preferable.
【0022】かかるコショウ科植物としては、成熟し
た、または未成熟の果実、果皮、種子、葉、葉柄、枝、
根、花等が原料として用いられるが、その中でも果実、
果皮、葉が好ましい。但し、上記コショウ科植物のう
ち、コショウ(Piper nigrum L.)は香
辛料として広く用いられ、発汗や健胃作用を有すること
が知られているが、食用と供されるものは、未成熟果実
を乾燥させた黒胡椒、成熟果実の外果皮を除去して乾燥
させた白胡椒と呼ばれるものである。これに対し、本発
明の目的において用いる場合は、黒胡椒に用いる未成熟
果実より更に未成熟な緑色の果実を用いることが好まし
い。Such pepper plants include mature or immature fruits, peels, seeds, leaves, petioles, branches,
Roots, flowers, etc. are used as raw materials, but among them, fruits,
Peel and leaves are preferred. However, among the above-mentioned pepper plants, pepper (Piper nigrum L.) is widely used as a spice and is known to have sweating and stomachic action, but those used for food use immature fruits. It is called dried black pepper or white pepper that has been dried by removing the outer skin of the mature fruit. On the other hand, when it is used for the purpose of the present invention, it is preferable to use a green fruit which is more immature than the immature fruit used for black pepper.
【0023】本発明におけるコショウ科植物は、水溶性
溶剤抽出物として使用される。溶剤抽出物としては、水
または低級アルコール、ポリオール等の有機溶媒あるい
はこれらの混合溶媒で抽出したものを挙げることがで
き、これは適宜濃縮、精製、滅菌、乾燥等を施して使用
される。The pepper plant of the present invention is used as a water-soluble solvent extract. Examples of the solvent extract include those extracted with water or an organic solvent such as a lower alcohol or a polyol, or a mixed solvent thereof, which is used after being appropriately concentrated, purified, sterilized, dried and the like.
【0024】本発明に用いられるアザミ族の植物として
は、アレチアザミ属のアレチアザミ(Cephalon
oplos segetum (Bieb.)Kita
m.)、エゾノキツネアザミ(Cephalonopl
os setosum(Bieb.)Kitam.);
アザミ属のフジアザミ(Cirsium purpur
atum(Maxim.)Matsum.)、タカアザ
ミ(Cirsiumpendulum Fische
r)、ウゴアザミ(Cirsium ugoense
Nakai)、アルバヒレアザミ(Cirsium g
rayanum(Maxim.)Nakai)、チシマ
アザミ(Cirsium kamtschaticum
Ledeb.)、キセルアザミ(Cirsium s
ieboldii Miq.)、テリハアザミ(Cir
sium lucens Kitam.)、サワアザミ
(Cirsium yezoense(Maxim.)
Makino)、サンベサワアザミ(Cirsium
tenuisquamatum Kitam.)、ワタ
ムキアザミ(Cirsium tashiroiKit
am.)、ヒダアザミ(Cirsium hidaen
se Kitam.)、オイランアザミ(Cirsiu
m spinosum Kitam.)、ハマアザミ
(Cirsium maritimum Makin
o)、シマアザミ(Cirsium brevicau
le A.Gray)、オガサワラアザミ(Cirsi
um boninense Koidz.)、ノアザミ
(Cirsium japonicum DC.)、タ
カサゴアザミ(Cirsiumjaponicum D
C.var australe Kitam.)、シロ
バナタカサゴアザミ(Cirsium joponic
um DC.vartakaoense Kita
m.)、ノハラアザミ(Cirsium oligop
hyllum(Franch.et Savat.)M
atsum.)、チョウカイアザミ(Cirsium
chokaiense Kitam.)、オニアザミ
(Cirsium borealinipponens
e Kitam.)、ジョウシュウオニアザミ(Cir
sium okamotoi Kitam.)、ムラク
モアザミ(Cirsium maruyamanum
Kitam.)、オニオオノアザミ(Cirsium
diabolicum Kitam.)、イナベアザミ
(Cirsium magofukui Kita
m.)、ヤナギアザミ(Cirsium linear
e(Thunb.)SchBip.)、モリアザミ(C
irsium dipsacolepis(Maxi
m.)Matsum.)、カガノアザミ(Cirsiu
m kagamontanum Nakai)、スズキ
アザミ(Cirsium suzukii Kita
m.)、ギョウジャアザミ(Cirsium gyoj
anum Kitam.)、コイブキアザミ(Cirs
ium confertissimumNakai)、
ビッチュウアザミ(Cirsium bitchuen
se Nakai)、アイズヒメアザミ(Cirsiu
m aidzuense Nakai)、ヒメアザミ
(Cirsium buevgeri Miq.)、ナ
ガエノアザミ(Cirsium longepedun
culatum Kitam.)、エゾヤマアザミ(C
irsium heiianum Koidz.)、ス
ズカアザミ (Cirsium suzukaense
Kitam.)、ウラジロカガノアザミ(Cirsi
um furusei Kitam.)、ホソエノアザ
ミ(Cirsium effusum(Maxim.)
Matsum.)、ヒッツキアザミ(Cirsium
congestissimum Kitam.)、ヤマ
アザミ(Cirsium spicatum(Maxi
m.)Matsum.)、ウスバアザミ(Cirsiu
m tenue Kitam.)、アズマヤマアザミ
(Cirsium microspicatum Na
kai)、タチアザミ(Cirsium inunda
tum Makino)、ノリクラアザミ(Cirsi
um norikurense Nakai)、ダキバ
ヒメアザミ(Cirsium amplexifoli
um Kitam.)、ハクサンアザミ(Cirsiu
m matsumurae Nakai)、ガンジュア
ザミ(Cirsium ganjuense Kita
m.)、タテヤマアザミ(Cirsium baban
um Koidz.var otayae(Kita
m.))、ツクシアザミ(Cirsium suffu
ltum(Maxim.)Matsum.)、ナンブア
ザミ(Cirsium nipponicum(Max
im.)Makino)、ヤクシマアザミ(Cirsi
umyakushimense Masam.)、ノマ
アザミ(Cirsiumchikushiense K
oidz.)、ハナマキアザミ(Cirsiumhan
amakiense Kitam.);ヒレアザミ属の
ヒレアザミ(Carduns cripus L。);
トウヒレン属のヒメヒゴタイ(Saussurea p
ulcheila Fischer)、トウヒゴタイ
(Saussurea japonica(Thun
b.)DC.)、ユキバヒゴタイ(Saussurea
chionophylla Takeda)、シラネ
アザミ(Saussurea nikoensis F
ranch et Savat.)、イワテヒゴタイ
(Saussurea brachycephala
Franch.)、ミヤマキタアザミ(Saussur
ea franchetii Koidz.)、ウスユ
キトウヒレン(Saussurea yanagisa
wae Takeda)、フォリイアザミ(Sauss
urea fauriei Franch.)、ホクチ
アザミ(Saussurea gracilis Ma
xim.)、キリシマヒゴタイ(Saussurea
scaposa Franch et Sava
t.);キツネアザミ属のキツネアザミ(Hemist
epta lyrata Bunge);ヤマボクチ属
のハバヤマボクチ(Synurus excelsus
(Makino)Kitam.)、ヤマボクチ(Syn
urus palmatopinn atifidus
(Makino)Kitam.var indivis
us Kitam.)、オヤマボクチ(Synurus
pungens(Franch et Sava
t.)Kitam.);タムラソウ属のタムラソウ(S
erratula coronata L.Subs
p.insularis(Iljin)Kita
m.);オケラ属のオケラ(Atractylodes
japonica Koidz.exKita
m.);ヒゴタイ属のヒゴタイ(Echinops s
etifer Iljin)などが挙げられる。これら
の中でもアレチアザミ属、アザミ属及びヒレアザミ属の
ものが好ましく、特にその中でもアレチアザミ、エゾノ
キツネアザミ、オニアザミ、ヤマアザミ、ノアザミ、ノ
ハラアザミ、ハマアザミ、タカサゴアザミ及びヒレアザ
ミが好ましい。なお、これらアザミ族植物のうち、アレ
チアザミ及びノアザミ等は止血や消炎、利尿作用があ
り、生薬として知られている。The plants of thistle family used in the present invention include Cephalon which belongs to the genus Alethisia.
oplos segmentum (Bieb.) Kita
m. ), Ezo fox thistle (Cephalonopl
os setosum (Bieb.) Kitam. );
Cirsium purpur
atum (Maxim.) Matsum. ), Thistle (Cirsium pendulum Fische)
r), thistle (Cirsium ugoense)
Nakai), Aruba hire thistle (Cirsium g)
rayanum (Maxim.) Nakai), thistle (Cirsium kamtschaticum)
Ledeb. ), Thistle (Cirsium s)
ieboldii Miq. ), Teriha Thistle (Cir
sium lucens Kitam. ), Cirsium yezoense (Maxim.)
Makino), Thistle Beetle (Cirsium)
tenuisquamatum Kitam. ), Yellow thistle (Cirsium tashiroi Kit)
am. ), Thistle (Cirsium hidaen)
se Kitam. ), Thistle (Cirsiu)
m spinosum Kitam. ), Thistle (Cirsium maritimum Makin)
o), thistle (Cirsium brevicau)
le A. Gray), Greater thistle (Cirsi)
um boninense Koidz. ), Thistle (Cirsium japonicum DC.), And coral thistle (Cirsium japonicum D)
C. var australe Kitam. ), White thistle (Cirsium Joponic)
um DC. vartakaoense Kita
m. ), Nora Thistle (Cirsium oligop)
hyllum (Franch. et Savat.) M
atsum. ), Thistle (Cirsium)
chokaiense Kitam. ), Cirsium borealininipponens
e Kitam. ), Dwarf Milk Thistle (Cir
sium okamotoi Kitam. ), Murakumo thistle (Cirsium maruyama manum)
Kitam. ), Water thistle (Cirsium)
diabolicum Kitam. ), Rice Cirrus (Cirsium magofukui Kita)
m. ), Yanagia thistle (Cirsium linear)
e (Thunb.) SchBip. ), Mori thistle (C
irsium dipsacorepis (Maxi
m. ) Matsum. ), Thistle (Cirsiu)
m kagamontanum Nakai), Suzuki thistle (Cirsium suzukii Kita)
m. ), Gold thistle (Cirsium gyoj)
anum Kitam. ), Koibu thistle (Cirs
ium confertissimum Nakai),
Thistle (Cirsium bitchuen)
se Nakai), Eyes thistle (Cirsiu)
m aidzuense Nakai), thistle (Cirsium buevgeri Mix), Nagano thistle (Cirsium longepedun)
curatum Kitam. ), Thistle thistle (C
irsium heianium Koidz. ), Thistle (Cirsium suzukiense)
Kitam. ), White veil thistle (Cirsi
um furusei Kitam. ), White thistle (Cirsium effusum (Maxim.)
Matsum. ), Hit thistle (Cirsium)
congestissimum Kitam. ), Thistle (Cirsium spicatum (Maxi
m. ) Matsum. ), Thistle (Cirsiu)
m tenue Kitam. ), Azumayama thistle (Cirsium microspicatum Na
kai), thistle (Cirsium inunda)
tum Makino), Norikura Thistle (Cirsi)
um norikurense Nakai, Cirsium amplififolia
um Kitam. ), Chinese thistle (Cirsiu)
m matsumurae Nakai, Cirsium ganjuense Kita
m. ), Thistle (Cirsium baban)
um Koidz. var otayae (Kita
m. )), Cirsicum suffu
ltum (Maxim.) Matsum. ), Thistle (Cirsium nipponicum (Max
im. ) Makino), Yakushima thistle (Cirsi)
umyakushimense Masam. ), Thistle (Cirsium chikushiense K)
oidz. ), Thistle (Cirsium han)
amakise Kitam. ); Cardiac crispus L. of the genus Cirea;
Saussurea p
ulcheila Fisher, Saussurea japonica (Thun
b. ) DC. ), Yukiba Higotai (Saussurea)
Chionophylla Takeda), white thistle (Saussurea nikoensis F)
Ranch et Savat. ), Iwatehigotai (Saussurea brachycephala)
French. ), Miyama thistle (Saussur
ea franchetii Koidz. ), Saussurea yanagisa
wae Takeda), Folly thistle (Sauss)
urea faurii Franch. ), White thistle (Saussurea gracilis Ma)
xim. ), Kirishima Higotai (Saussurea)
scaposa French et Sava
t. ); Leopard thistle (Hemist)
epta lyrata Bunge); Synemus excelsus of the genus Yamabuchi
(Makino) Kitam. ), Yamabokuchi (Syn
urus palmatopinn atifidus
(Makino) Kitam. var indivis
us Kitam. ), Oyamabokuchi (Synurus)
pungens (Franch et Sava
t. ) Kitam. ); Tamurasou of the genus Tamurasou (S
erratula coronata L. Subs
p. insularis (Iljin) Kita
m. ); Ochera (Atractylodes)
japonica Koidz. exKit
m. ); Higotai (Echinops s)
etifler Iljin) and the like. Among these, those of the genus Arechia, thistle and genus Thistle are particularly preferable, and among these, arele thistle, horned fox thistle, horned thistle, mountain thistle, thistle, nora thistle, thistle, octopus thistle and leaf thistle are preferable. In addition, among these plants of the thistle family, the holly thistle and the thistle etc. have haemostasis, anti-inflammatory and diuretic action, and are known as crude drugs.
【0025】本発明におけるアザミ族植物は、葉、頭
花、種子、茎、根及び全草を原料として用いることがで
き、その中でも特に根及び茎を用いるのが好ましい。The thistle plant of the present invention can be used with leaves, head flowers, seeds, stems, roots and whole plants as raw materials, and among them, it is particularly preferable to use roots and stems.
【0026】本発明におけるアザミ族植物は、水溶性溶
剤抽出物として使用される。溶剤抽出物としては、水ま
たは低級アルコール、ポリオール等の有機溶媒あるいは
これらの混合溶媒で抽出したものを挙げることができ、
これは適宜濃縮、精製、滅菌、乾燥等を施して使用され
る。The thistle plant in the present invention is used as a water-soluble solvent extract. Examples of the solvent extract include water or lower alcohols, those extracted with an organic solvent such as polyol or a mixed solvent thereof,
This is used after being appropriately concentrated, purified, sterilized, dried and the like.
【0027】その他の抽出物についても、抽出方法は特
に限定されるものではなく、例えば水、アルコール等の
親水性有機溶剤、あるいはそれらの混合液、またはグリ
セリン、1,3−ブチレングリコール等の多価アルコー
ル、あるいは水と多価アルコールとの混合液により抽出
される。これらは適宜濃縮、精製、滅菌、乾燥等を施し
て使用される。With respect to the other extracts, the extraction method is not particularly limited, and examples thereof include hydrophilic organic solvents such as water and alcohol, mixed solutions thereof, and glycerin, 1,3-butylene glycol and the like. It is extracted with a polyhydric alcohol or a mixed liquid of water and a polyhydric alcohol. These are appropriately concentrated, purified, sterilized, dried, etc. before use.
【0028】ベルベリン型アルカロイドとしては、一般
式(1):The berberine-type alkaloid has the general formula (1):
【0029】[0029]
【化1】 [Chemical 1]
【0030】(式中、R1およびR2は、同一または異な
って、炭素数1〜5のアルキル基を表し、nは1〜5の
整数を表し、Xは1価の陰イオンを表す。)で示される
ベルベリン塩またはその誘導体、一般式(2):(In the formula, R 1 and R 2 are the same or different and each represents an alkyl group having 1 to 5 carbon atoms, n represents an integer of 1 to 5, and X represents a monovalent anion. ), A berberine salt or a derivative thereof represented by the general formula (2):
【0031】[0031]
【化2】 [Chemical 2]
【0032】(式中、R1,R2,R3およびR4は、同一
または異なって、炭素数1〜5のアルキル基を表し、X
は1価の陰イオンを表す。)で示されるパルマチン塩ま
たはその誘導体、および一般式(3):(In the formula, R 1 , R 2 , R 3 and R 4 are the same or different and each represents an alkyl group having 1 to 5 carbon atoms;
Represents a monovalent anion. ) And a derivative thereof, and a general formula (3):
【0033】[0033]
【化3】 [Chemical 3]
【0034】(式中、nおよびmはそれぞれ1〜5の整
数を表し、Xは1価の陰イオンを表す。)で示されるコ
プチジン塩またはその誘導体が好ましい。(In the formula, n and m each represent an integer of 1 to 5, and X represents a monovalent anion.), And a coptidine salt or a derivative thereof is preferable.
【0035】R1およびR2が共にメチル基であり、nが
1であり、Xが塩素イオンである一般式(1)で示され
る塩化ベルベリン、またはR1〜R4がすべてメチル基で
あり、Xが塩素イオンである一般式(2)で示される塩
化パルマチンは、ミカン科のキハダPhelloden
dron amurenseおよびその変種、またはP
hellodendron chinenseおよびそ
の変種のコルク層を除いた樹皮、メギ科のメギBerb
eris thunbergiiの木部、ツツラフジ科
のコロンボJateorhiza columbaの根
などに含まれ、大腸菌、コレラ菌、チフス菌などグラム
陰性菌に強い抗菌作用を示し、健胃、整腸、殺菌剤とし
て、細菌性の下痢、腸内異常発酵などに、また打撲傷の
湿布薬、目薬などに用いられる。Berberine chloride represented by the general formula (1) in which R 1 and R 2 are both methyl groups, n is 1 and X is a chlorine ion, or R 1 to R 4 are all methyl groups , X is a chlorine ion, the palmatine chloride represented by the general formula (2) is a yellow-billed Phelloden of the Rutaceae family.
dron amurense and its variants, or P
Cork-layer-excluded bark of Heldendron chinense and its variants, Barberry Berb of the family Barberry
eris thumbergii xylem, contained in the roots of Colombo Jateorhiza columba of the family Aceraceae, has a strong antibacterial action against Gram-negative bacteria such as Escherichia coli, cholera, typhoid, and is a bacterial agent as a stomach, intestine, and bactericide. It is used for diarrhea, abnormal intestinal fermentation, etc., and for poultice and eye drops for bruising.
【0036】nおよびmが共に1であり、Xが塩素イオ
ンである一般式(3)で示される塩化コプチジンは、キ
ンポウゲ科のオウレンCoptis japonica
またはCoptis japonica var.di
ssectaの根茎に含まれ、苦味健胃薬、整腸薬、消
炎収斂薬として胃腸炎、腹痛、黄疸、下痢などに、また
打撲傷の湿布薬、目薬などに用いられている。Coptidine chloride represented by the general formula (3) in which n and m are both 1 and X is a chloride ion is a Coptis japonica of the buttercup family.
Or the Coptis japonica var. di
It is contained in the rhizome of secta, and is used as a bitter stomachic medicine, intestinal medicine, anti-inflammatory and astringent medicine for gastroenteritis, abdominal pain, jaundice, diarrhea, etc., and for poultice and eye drops for bruises.
【0037】ベルベリン塩またはその誘導体、パルマチ
ン塩またはその誘導体、およびコプチジン塩またはその
誘導体は、それぞれ単独で用いても、またはいずれか2
種以上を組み合わせて用いてもよい。The berberine salt or its derivative, the palmatine salt or its derivative, and the coptidine salt or its derivative may be used alone or in any two of them.
You may use it in combination of 2 or more types.
【0038】これらのベルベリン型アルカノイドとして
は、上記植物より抽出精製したもの、合成品、さらにオ
ウレンのカルス培養体より抽出精製したものなどが使え
る。さらに塩化ベルベリン、塩化パルマチン、または塩
化コプチジンを含有するキハダ、コロンボ根、メギ、オ
ウレンなどの抽出エキス、またはこれらのエキスを分画
したものなどを用いることもできる。As these berberine-type alkanoids, those extracted and purified from the above plants, synthetic products, and those extracted and purified from callus cultures of Coptis chinensis can be used. Furthermore, it is also possible to use extracts such as yellowfin, colombo root, barberry, oren containing berberine chloride, palmatine chloride or coptidine chloride, or fractionated products of these extracts.
【0039】ベルベリン型アルカノイドの抽出には、溶
媒として水、メタノール、エタノール、イソプロピルア
ルコール、ブタノール、酢酸エチル、アセトン、エーテ
ル、クロロホルムなどを用いることができる。これらの
溶媒は2種以上を組み合わせて使用してもよい。これら
のうち特に好ましい溶媒は、水、メタノール、エタノー
ルである。Water, methanol, ethanol, isopropyl alcohol, butanol, ethyl acetate, acetone, ether, chloroform and the like can be used as a solvent for the extraction of berberine type alkanoides. You may use these solvents in combination of 2 or more types. Of these, particularly preferable solvents are water, methanol and ethanol.
【0040】本発明で用いられるツヅラフジ科植物は約
20種余りを含み、例えばオオツヅラフジ(根茎および
/または茎は防已と呼ばれる。)、アオツヅラフジ、イ
ソヤマアオキ、ツヅラフジ、タマサキツヅラフジ、ミヤ
コジマツヅラフジ、ホウライツヅラフジ、コウモリカズ
ラ、ハスノハカズラ、シマハスノハカズラ、アオカズ
ラ、コウシュウウヤク、コロンボ等が挙げられる。これ
らの中でも特にオオツヅラフジの根茎および/または茎
(防已)が望ましい。The plant of the family Amaranthaceae used in the present invention includes about 20 species or more. For example, Amaranthaceae (rhizome and / or stem is referred to as "preserved"), Aotsutsurafuji, Isoyama Aoki, Tsutsurafuji, Tamasakitsuduji, Miyakojitsuduji, Examples include Hora-itsuduraji, bats, pearl vines, vine vines, vine vines, blue vines, pearl oysters, and colombo. Among these, rhizome and / or stem (prevented) of Otsutsurafuji are particularly preferable.
【0041】これらの植物は、花、茎、果実、種子、
根、全草等が用いられ、好ましくは、ツヅラフジ科植物
は、根茎および/または茎が用いられる。抽出方法は特
に限定されるものではなく、例えば水、アルコール等の
親水性有機溶剤、あるいはそれらの混合液、またはグリ
セリン、1,3−ブチレングリコール等の多価アルコー
ル、あるいは水と多価アルコールとの混合液により抽出
される。These plants include flowers, stems, fruits, seeds,
Roots, whole plants, etc. are used, and preferably, rhizomes and / or stems are used for plants of the family Astragalus. The extraction method is not particularly limited, for example, water, a hydrophilic organic solvent such as alcohol, or a mixed solution thereof, or glycerin, a polyhydric alcohol such as 1,3-butylene glycol, or water and a polyhydric alcohol. It is extracted with a mixed solution of.
【0042】本発明において、キョウニン抽出物類と併
用する他の成分(A)の皮膚外用剤中ヘの配合量は、乾
燥物換算で0.001〜30.0重量%、好ましくは
0.01〜20.0重量%である。In the present invention, the amount of the other component (A) used in combination with the Kyounin extract in the external preparation for skin is 0.001 to 30.0% by weight in terms of dry matter, preferably 0.01. ~ 20.0% by weight.
【0043】本発明の皮膚外用剤は、必要に応じて、本
発明の効果を損なわない範囲で、化粧品、医薬品等に一
般に用いられている各種成分を含めることができる。こ
のような成分としては次のようなものが挙げられる。The external preparation for skin of the present invention may contain, if necessary, various components generally used in cosmetics, pharmaceuticals and the like within a range that does not impair the effects of the present invention. Examples of such components include the following.
【0044】ビタミン油,レチノール,酢酸レチノール
等のビタミンA類、リボフラビン,酪酸リボフラビン,
フラビンアデニンヌクレオチド等のビタミンB2類、ピ
リドキシン塩酸塩,ピリドキシンジオクタノエート等の
ビタミンB6類、L−アスコルビン酸,L−アスコルビ
ン酸ジパルミチン酸エステル,L−アスコルビン酸−2
−硫酸ナトリウム,L−アスコルビン酸リン酸エステ
ル,L−アスコルビン酸グルコシド,DL−α−トコフ
ェロール−L−アスコルビン酸リン酸ジエステルジカリ
ウム等のビタミンC類、パントテン酸カルシウム,D−
パントテニルアルコール,パントテニルエチルエーテ
ル,アセチルパントテニルエチルエーテル等のパントテ
ン酸類、エルゴカルシフェロール,コレカルシフェロー
ル等のビタミンD類、ニコチン酸,ニコチン酸アミド,
ニコチン酸ベンジル等のニコチン酸類、α−トコフェロ
ール,酢酸トコフェロール,ニコチン酸DL−α−トコ
フェロール,コハク酸DL−α−トコフェロール等のビ
タミンE類、ビタミンP、ビオチン等のビタミン類が挙
げられる。Vitamin oils, vitamins A such as retinol and retinol acetate, riboflavin, riboflavin butyrate,
Vitamin B2 such as flavin adenine nucleotide, pyridoxine hydrochloride, vitamin B6 such as pyridoxine dioctanoate, L-ascorbic acid, L-ascorbic acid dipalmitate, L-ascorbic acid-2
-Vitamin Cs such as sodium sulfate, L-ascorbic acid phosphate, L-ascorbic acid glucoside, DL-α-tocopherol-L-ascorbic acid diester dipotassium, calcium pantothenate, D-
Pantothenic alcohols such as pantothenyl alcohol, pantothenyl ethyl ether, acetyl pantothenyl ethyl ether, vitamin Ds such as ergocalciferol and cholecalciferol, nicotinic acid, nicotinic acid amide,
Examples thereof include nicotinic acid such as benzyl nicotinate, vitamin Es such as α-tocopherol, tocopherol acetate, DL-α-tocopherol nicotinate and DL-α-tocopherol succinate, and vitamins such as vitamin P and biotin.
【0045】液体油脂としては、アボガド油,ツバキ
油,月見草油,タートル油,マカデミアナッツ油,トウ
モロコシ油,ミンク油,オリーブ油,ナタネ油,卵黄
油,ゴマ油,パーシック油,小麦胚芽油,サザンカ油,
ヒマシ油,アマニ油,サフラワー油,綿実油,エノ油,
大豆油,落花生油,茶実油,カヤ油,コメヌカ油,シナ
ギリ油,日本キリ油,ホホバ油,胚芽油,トリグリセリ
ン,トリオクタン酸グリセリン,トリイソパルミチン酸
グリセリン等が、固体油脂としては、カカオ脂,ヤシ
油,馬脂,硬化ヤシ油,パーム油,牛脂,羊脂,硬化牛
脂,パーム核油,豚脂,牛骨脂,モクロウ核油,硬化
油,牛脚脂,モクロウ,硬化ヒマシ油等、ロウ類として
は、ミツロウ,カンデリラロウ,綿ロウ,カルナウバロ
ウ,ベイベリーロウ,イボタロウ,鯨ロウ,モンタンロ
ウ,ヌカロウ,ラノリン,カポックロウ,酢酸ラノリ
ン,液状ラノリン,サトウキビロウ,ラノリン脂肪酸イ
ソプロピル,ラウリン酸ヘキシル,還元ラノリン,ホホ
バロウ,硬質ラノリン,セラックロウ,POEラノリン
アルコールエーテル,POEラノリンアルコールアセテ
ート,POEコレステロールエーテル,ラノリン脂肪酸
ポリエチレングリコール,POE水素添加ラノリンアル
コールエーテル等、炭化水素油としては、流動パラフィ
ン,オゾケライト,スクワラン,プリスタン,パラフィ
ン,セレシン,スクワレン,ワセリン,マイクロクリス
タリンワックス等が、精油類としてはハッカ油、ジャス
ミン油、ショウノウ油、ヒノキ油、トウヒ油、リュウ
油、テレピン油、ケイ皮油、ベルガモット油、ミカン
油、ショウブ油、パイン油、ラベンダー油、ベイ油、ク
ローブ油、ヒバ油、バラ油、ユーカリ油、レモン油、タ
イム油、ペパーミント油、ローズ油、セージ油、メント
ール、シネオール、オイゲノール、シトラールシトロネ
ラール、ボルネオール、リナロール、ゲラニオール、カ
ンファー、チモール、スピラントール、ピネン、リモネ
ン、テルペン系化合物の油分が挙げられる。The liquid oils and fats include avocado oil, camellia oil, evening primrose oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil,
Castor oil, linseed oil, safflower oil, cottonseed oil, eno oil,
Soybean oil, peanut oil, teaseed oil, kaya oil, rice bran oil, cinnamon oil, Japanese tung oil, jojoba oil, germ oil, triglycerin, glyceryl trioctanoate, glyceryl triisopalmitate, etc., are solid cacao. Fat, coconut oil, horse fat, hydrogenated coconut oil, palm oil, beef tallow, sheep fat, hydrogenated beef tallow, palm kernel oil, pork fat, beef bone fat, mokuro kernel oil, hydrogenated oil, beef tallow, mokurou, hydrogenated castor oil As waxes, beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ivota wax, whale wax, montan wax, nukarou, lanolin, capock wax, lanolin acetate, liquid lanolin, sugarcane wax, lanolin fatty acid isopropyl, hexyl laurate, reduced lanolin. , Jojoba wax, hard lanolin, shellac wax, POE lanolin alcohol ether, P E lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether and the like, hydrocarbon oils include liquid paraffin, ozokerite, squalane, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, etc. , As essential oils, peppermint oil, jasmine oil, camphor oil, cypress oil, spruce oil, ryu oil, turpentine oil, cinnamon oil, bergamot oil, mandarin oil, chive oil, pine oil, lavender oil, bay oil, clove oil. , Hiba oil, rose oil, eucalyptus oil, lemon oil, thyme oil, peppermint oil, rose oil, sage oil, menthol, cineole, eugenol, citral citronellal, borneol, linalool, geranio Le, camphor, thymol, spilanthol, pinene, limonene, include oil of terpene compounds.
【0046】高級脂肪酸としては、例えば、ラウリン
酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘ
ン(ベヘニン)酸、オレイン酸、12−ヒドロキシステ
アリン酸、ウンデシレン酸、トール酸、イソステアリン
酸、リノール酸、リノレイン酸、エイコサペンタエン酸
(EPA)、ドコサヘキサエン酸(DHA)等が挙げら
れる。Examples of the higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid (beheninic acid), oleic acid, 12-hydroxystearic acid, undecylenic acid, tall acid, isostearic acid, linoleic acid and linolein. Acid, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and the like.
【0047】高級アルコールとしては、例えば、ラウリ
ルアルコール、セチルアルコール、ステアリルアルコー
ル、ベヘニルアルコール、ミリスチルアルコール、オレ
イルアルコール、セトステアリルアルコール等の直鎖ア
ルコール、モノステアリルグリセリンエーテル(バチル
アルコール)、2−デシルテトラデシノール、ラノリン
アルコール、コレステロール、フィトステロール、ヘキ
シルドデカノール、イソステアリルアルコール、オクチ
ルドデカノール等の分枝鎖アルコール等が挙げられる。Examples of higher alcohols include linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol and cetostearyl alcohol, monostearyl glycerin ether (batyl alcohol), 2-decyltetradecyl alcohol. Examples thereof include branched chain alcohols such as knoll, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, and octyldodecanol.
【0048】合成エステル油としては、ミリスチン酸イ
ソプロピル、オクタン酸セチル、ミリスチン酸オクチル
ドデシル、パルミチン酸イソプロピル、ステアリン酸ブ
チル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、
オレイン酸デシル、ジメチルオクタン酸ヘキシルデシ
ル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステ
アリン酸イソセチル、イソステアリン酸イソセチル、1
2−ヒドロキシステアリン酸コレステリル、ジ−2−エ
チルヘキシル酸エチレングリコール、ジペンタエリスリ
トール脂肪酸エステル、モノイソステアリン酸N−アル
キルグリコール、ジカプリン酸ネオペンチルグリコー
ル、リンゴ酸ジイソステアリル、ジ−2−ヘプチルウン
デカン酸グリセリン、トリ−2−エチルヘキシル酸トリ
メチロールプロパン、トリイソステアリン酸トリメチロ
ールプロパン、テトラ−2−エチルヘキシル酸ペンタン
エリスリトール、トリ−2−エチルヘキシル酸グリセリ
ン、トリイソステアリン酸トリメチロールプロパン、セ
チル2−エチルヘキサノエート、2−エチルヘキシルパ
ルミテート、トリミリスチン酸グリセリン、トリ−2−
ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メ
チルエステル、オレイン酸オレイル、セトステアリルア
ルコール、アセトグリセライド、パルミチン酸2−ヘプ
チルウンデシル、アジピン酸ジイソブチル、N−ラウロ
イル−L−グルタミン酸−2−オクチルドデシルエステ
ル、アジピン酸ジ−2−ヘプチルウンデシル、エチルラ
ウレート、セバチン酸ジ−2−エチルヘキシル、ミリス
チン酸2−ヘキシルデシル、パルミチン酸2−ヘキシル
デシル、アジピン酸2−ヘキシルデシル、セバチン酸ジ
イソプロピル、コハク酸2−エチルヘキシル、酢酸エチ
ル、酢酸ブチル、酢酸アミル、クエン酸トリエチル等が
挙げられる。The synthetic ester oils include isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate,
Decyl oleate, hexyldecyl dimethyloctanoate, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, 1
Cholesteryl 2-hydroxystearate, ethylene glycol di-2-ethylhexylate, dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, neopentyl glycol dicaprate, diisostearyl malate, glycerin di-2-heptylundecanoate. Trimethylolpropane tri-2-ethylhexylate, trimethylolpropane triisostearate, penta-2-erythritol tetrahexylhexanoate, glycerin tri-2-ethylhexylate, trimethylolpropane triisostearate, cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, glycerin trimyristate, tri-2-
Heptylundecanoic acid glyceride, castor oil fatty acid methyl ester, oleyl oleate, cetostearyl alcohol, acetoglyceride, 2-heptylundecyl palmitate, diisobutyl adipate, N-lauroyl-L-glutamic acid-2-octyldodecyl ester, adipic acid Di-2-heptyl undecyl, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, diisopropyl sebacate, 2-ethylhexyl succinate. , Ethyl acetate, butyl acetate, amyl acetate, triethyl citrate and the like.
【0049】シリコーンとしては、例えば、ジメチルポ
リシロキサン、メチルフェニルポリシロキサン、メチル
ハイドロジェンポリシロキサン等の鎖状ポリシロキサ
ン、デカメチルシクロポリシロキサン、ドデカメチルシ
クロポリシロキサン、テトラメチルテトラハイドロジェ
ンシクロポリシロキサンなどの環状ポリシロキサン、3
次元網目構造を形成しているシリコーン樹脂、シリコー
ンゴム等が挙げられる。Examples of the silicone include chain polysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane, decamethylcyclopolysiloxane, dodecamethylcyclopolysiloxane, and tetramethyltetrahydrogencyclopolysiloxane. Cyclic polysiloxanes such as 3
Examples thereof include silicone resin and silicone rubber that form a three-dimensional network structure.
【0050】保湿剤としては、例えばポリエチレングリ
コール、プロピレングリコール、グリセリン、1,3−
ブチレングリコール、ヘキシレングリコール、キシリト
ール、ソルビトール、マルチトール、コンドロイチン硫
酸、ヒアルロン酸、ムコイチン硫酸、カロニン酸、アテ
ロコラーゲン、コレステリル−12−ヒドロキシステア
レート、乳酸ナトリウム、胆汁酸塩、dl−ピロリドン
カルボン酸塩、短鎖可溶性コラーゲン、ジグリセリン
(EO)PO付加物、イザヨイバラ抽出物、セイヨウノ
コギリソウ抽出物、メリロート抽出物等が挙げられる。Examples of moisturizers include polyethylene glycol, propylene glycol, glycerin, 1,3-
Butylene glycol, hexylene glycol, xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronic acid, atelocollagen, cholesteryl-12-hydroxystearate, sodium lactate, bile salt, dl-pyrrolidone carboxylate, Examples thereof include short-chain soluble collagen, diglycerin (EO) PO adduct, Iris yezoensis extract, Yarrow extract and Merrilot extract.
【0051】紫外線吸収剤としては、パラアミノ安息香
酸(以下PABAと略す)、PABAモノグリセリンエ
ステル、N,N−ジプロポキシPABAエチルエステ
ル、N,N−ジエトキシPABAエチルエステル、N,
N−ジメチルPABAエチルエステル、N,N−ジメチ
ルPABAブチルエステル等の安息香酸系紫外線吸収
剤、ホモメンチル−N−アセチルアントラニレート等の
アントラニル酸系紫外線吸収剤、アミルサリシレート、
メンチルサリシレート、ホモメンチルサリシレート、オ
クチルサリシレート、フェニルサリシレート、ベンジル
サリシレート、p−イソプロパノールフェニルサリシレ
ート等のサリチル酸系紫外線吸収剤、オクチルシンナメ
ート、エチル−4−イソプロピルシンナメート、メチル
−2,5−ジイソプロピルシンナメート、エチル−2,
4−ジイソプロピルシンナメート、メチル−2,4−ジ
イソプロピルシンナメート、プロピル−p−メトキシシ
ンナメート、イソプロピル−p−メトキシシンナメー
ト、イソアミル−p−メトキシシンナメート、オクチル
−p−メトキシシンナメート(2−エチルヘキシル−p
−メトキシシンナメート)、2−エトキシエチル−p−
メトキシシンナメート、シクロヘキシル−p−メトキシ
シンナメート、エチル−α−シアノ−β−フェニルシン
ナメート、2−エチルヘキシル−α−シアノ−β−フェ
ニルシンナメート、グリセリルモノ−2−エチルヘキサ
ノイル−ジパラメトキシシンナメート、3,4,5−ト
リメトキシ桂皮酸3−メチル−4−[メチルビス(トリ
メチルシロキシ)シリル]ブチル等の桂皮酸系紫外線吸
収剤、2,4−ジヒドロキシベンゾフェノン、2,2’
−ジヒドロキシ−4−メトキシベンゾフェノン、2,
2’−ジヒドロキシ−4,4’−ジメトキシベンゾフェ
ノン、2,2’,4,4’−テトラヒドロキシベンゾフ
ェノン、2−ヒドロキシ−4−メトキシベンゾフェノ
ン、2−ヒドロキシ−4−メトキシ−4’−メチルベン
ゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェ
ノン−5−スルホン酸塩、4−フェニルベンゾフェノ
ン、2−エチルヘキシル−4’−フェニル−ベンゾフェ
ノン−2−カルボキシレート、2−ヒドロキシ−4−n
−オクトキシベンゾフェノン、4−ヒドロキシ−3−カ
ルボキシベンゾフェノン等のベンゾフェノン系紫外線吸
収剤、3−(4’−メチルベンジリデン)-d,1−カン
ファー、3−ベンジリデン−d,1−カンファー、ウロ
カニン酸、ウロカニン酸エチルエステル、2−フェニル
−5−メチルベンゾキサゾール、2,2’−ヒドロキシ
−5−メチルフェニルベンゾトリアゾール、2−(2’
−ヒドロキシ−5’−t−オクチルフェニル)ベンゾト
リアゾール、2−(2’−ヒドロキシ−5’−メチルフ
ェニルベンゾトリアゾール、ジベンザラジン、ジアニソ
イルメタン、4−メトキシ−4’−t−ブチルジベンゾ
イルメタン、5−(3,3−ジメチル−2−ノルボルニ
リデン)−3−ペンタン−2−オン等が挙げられる。As the ultraviolet absorber, para-aminobenzoic acid (hereinafter abbreviated as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester, N,
Benzoic acid type UV absorbers such as N-dimethyl PABA ethyl ester and N, N-dimethyl PABA butyl ester, anthranilic acid type UV absorbers such as homomenthyl-N-acetylanthranilate, amyl salicylate,
Salicylic acid type UV absorbers such as menthyl salicylate, homomenthyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate, p-isopropanol phenyl salicylate, octylcinnamate, ethyl-4-isopropylcinnamate, methyl-2,5-diisopropylcinnamate , Ethyl-2,
4-diisopropyl cinnamate, methyl-2,4-diisopropyl cinnamate, propyl-p-methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, octyl-p-methoxycinnamate (2- Ethylhexyl-p
-Methoxycinnamate), 2-ethoxyethyl-p-
Methoxycinnamate, cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate, 2-ethylhexyl-α-cyano-β-phenylcinnamate, glyceryl mono-2-ethylhexanoyl-diparamethoxy Cinnamates, cinnamic acid-based UV absorbers such as 3-methyl-4- [methylbis (trimethylsiloxy) silyl] butyl 3,4,5-trimethoxycinnamate, 2,4-dihydroxybenzophenone, 2,2 '
-Dihydroxy-4-methoxybenzophenone, 2,
2'-dihydroxy-4,4'-dimethoxybenzophenone, 2,2 ', 4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 4-phenylbenzophenone, 2-ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n
-Benzophenone-based UV absorbers such as octoxybenzophenone and 4-hydroxy-3-carboxybenzophenone, 3- (4'-methylbenzylidene) -d, 1-camphor, 3-benzylidene-d, 1-camphor, urocanic acid, Urocanic acid ethyl ester, 2-phenyl-5-methylbenzoxazole, 2,2'-hydroxy-5-methylphenylbenzotriazole, 2- (2 '
-Hydroxy-5'-t-octylphenyl) benzotriazole, 2- (2'-hydroxy-5'-methylphenylbenzotriazole, dibenzalazine, dianisoylmethane, 4-methoxy-4'-t-butyldibenzoylmethane, 5- (3,3-dimethyl-2-norbornylidene) -3-pentan-2-one and the like can be mentioned.
【0052】アニオン界面活性剤としては、例えば、セ
ッケン用素地、ラウリン酸ナトリウム、パルミチン酸ナ
トリウム等の脂肪酸セッケン、ラウリル硫酸ナトリウ
ム、ラウリル硫酸カリウム等の高級アルキル硫酸エステ
ル塩、POEラウリル硫酸トリエタノールアミン、PO
Eラウリル硫酸ナトリウム等のアルキルエーテル硫酸エ
ステル塩、ラウロイルサルコシンナトリウム等のN−ア
シルサルコシン酸、N−ミリストイル−N−メチルタウ
リンナトリウム、ヤシ油脂肪酸メチルタウリッドナトリ
ウム、ラウリルメチルタウリッドナトリウム等の高級脂
肪酸アミドスルホン酸塩、POEオレイルエーテルリン
酸ナトリウム、POEステアリルエーテルリン酸等のリ
ン酸エステル塩、ジ−2−エチルヘキシルスルホコハク
酸ナトリウム、モノラウロイルモノエタノールアミドポ
リオキシエチレンスルホコハク酸ナトリウム、ラウリル
ポリプロピレングリコールスルホコハク酸ナトリウム等
のスルホコハク酸塩、リニアドデシルベンゼンスルホン
酸ナトリウム、リニアドデシルベンゼンスルホン酸トリ
エタノールアミン、リニアドデシルベンゼンスルホン酸
等のアルキルベンゼンスルホン酸塩、N−ラウロイルグ
ルタミン酸モノナトリウム、N−ステアロイルグルタミ
ン酸ジナトリウム、N−ミリストイル−L−グルタミン
酸モノナトリウム等のN−アシルグルタミン酸塩、硬化
ヤシ油脂肪酸グリセリン硫酸ナトリウム等の高級脂肪酸
エステル硫酸エステル塩、ロート油等の硫酸化油、PO
Eアルキルエーテルカルボン酸、POEアルキルアリル
エーテルカルボン酸塩、α−オレフィンスルホン酸塩、
高級脂肪酸エステルスルホン酸塩、二級アルコール硫酸
エステル塩、高級脂肪酸アルキロールアミド硫酸エステ
ル塩、ラウロイルモノエタノールアミドコハク酸ナトリ
ウム、N−パルミトイルアスパラギン酸ジトリエタノー
ルアミン、カゼインナトリウム等が挙げられる。Examples of the anionic surfactant include a base for soap, a fatty acid soap such as sodium laurate and sodium palmitate, a higher alkyl sulfate ester salt such as sodium lauryl sulfate and potassium lauryl sulfate, POE lauryl sulfate triethanolamine, and the like. PO
E Alkyl ether sulfate ester salts such as sodium lauryl sulfate, N-acyl sarcosinic acid such as sodium lauroyl sarcosine, N-myristoyl-N-methyl taurine sodium, coconut oil fatty acid methyl tauride sodium, higher fatty acids such as sodium lauryl methyl tauride Amidosulfonate, sodium phosphate ester of POE oleyl ether phosphate, POE stearyl ether phosphate, etc., sodium di-2-ethylhexyl sulfosuccinate, monolauroyl monoethanolamide sodium polyoxyethylene sulfosuccinate, lauryl polypropylene glycol sulfosuccinate Sulfosuccinates such as sodium, sodium linear dodecylbenzene sulfonate, triethanolamine linear dodecylbenzene sulfonate Alkylbenzene sulfonates such as linear dodecylbenzene sulfonic acid, N-lauroyl glutamate monosodium, N-stearoyl glutamate disodium, N-myristoyl-L-glutamate monosodium and other N-acyl glutamate, hydrogenated coconut oil fatty acid glycerin sodium sulfate Higher fatty acid ester sulfate ester salt such as, sulfated oil such as funnel oil, PO
E alkyl ether carboxylic acid, POE alkyl allyl ether carboxylate, α-olefin sulfonate,
Examples thereof include higher fatty acid ester sulfonates, secondary alcohol sulfate ester salts, higher fatty acid alkylolamide sulfate ester salts, sodium lauroyl monoethanolamide succinate, ditriethanolamine N-palmitoyl aspartate, and sodium caseinate.
【0053】カチオン界面活性剤としては、例えば、塩
化ステアリルトリメチルアンモニウム、塩化ラウリルト
リメチルアンモニウム等のアルキルトリメチルアンモニ
ウム塩、塩化ジステアリルジメチルアンモニウムジアル
キルジメチルアンモニウム塩、塩化ポリ(N,N’−ジ
メチル−3,5−メチレンピペリジニウム),塩化セチ
ルピリジニウム等のアルキルピリジニウム塩、アルキル
四級アンモニウム塩、アルキルジメチルベンジルアンモ
ニウム塩、アルキルイソキノリニウム塩、ジアルキルモ
ルホニウム塩、POEアルキルアミン、アルキルアミン
塩、ポリアミン脂肪酸誘導体、アミルアルコール脂肪酸
誘導体、塩化ベンザルコニウム、塩化ベンゼトニウム等
が挙げられる。Examples of the cationic surfactant include alkyl trimethyl ammonium salts such as stearyl trimethyl ammonium chloride and lauryl trimethyl ammonium chloride, distearyl dimethyl ammonium dialkyl dimethyl ammonium chloride, poly (N, N'-dimethyl-3, 5-methylene piperidinium), an alkylpyridinium salt such as cetylpyridinium chloride, an alkyl quaternary ammonium salt, an alkyldimethylbenzylammonium salt, an alkylisoquinolinium salt, a dialkylmorphonium salt, a POE alkylamine, an alkylamine salt, Examples thereof include polyamine fatty acid derivatives, amyl alcohol fatty acid derivatives, benzalkonium chloride and benzethonium chloride.
【0054】両性界面活性剤としては、例えば、2−ウ
ンデシル−N,N,N−(ヒドロキシエチルカルボキシ
メチル)−2−イミダゾリンナトリウム、2−ココイル
−2−イミダゾリニウムヒドロキサイド−1−カルボキ
シエチロキシ2ナトリウム塩等のイミダゾリン系界面活
性剤、2−ヘプタデシル−N−カルボキシメチル−N−
ヒドロキシエチルイミダゾリニウムベタイン、ラウリル
ジメチルアミノ酢酸ベタイン、アルキルベタイン、アミ
ドベタイン、スルホベタイン等のベタイン系界面活性剤
等が挙げられる。Examples of the amphoteric surfactant include 2-undecyl-N, N, N- (hydroxyethylcarboxymethyl) -2-imidazoline sodium, 2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyl ester. Imidazoline surfactants such as roxy disodium salt, 2-heptadecyl-N-carboxymethyl-N-
Examples thereof include betaine-based surfactants such as hydroxyethyl imidazolinium betaine, lauryl dimethylamino acetic acid betaine, alkyl betaine, amido betaine and sulfobetaine.
【0055】親油性非イオン界面活性剤としては、例え
ば、ソルビタンモノオレエート、ソルビタンモノイソス
テアレート、ソルビタンモノラウレート、ソルビタンモ
ノパルミテート、ソルビタンモノステアレート、ソルビ
タンセスキオレエート、ソルビタントリオレエート、ペ
ンタ−2−エチルヘキシル酸ジグリセロールソルビタ
ン、テトラ−2−エチルヘキシル酸ジグリセロールソル
ビタン等のソルビタン脂肪酸エステル類、モノ綿実油脂
肪酸グリセリン、モノエルカ酸グリセリン、セスキオレ
イン酸グリセリン、モノステアリン酸グリセリン、α,
α’−オレイン酸ピログルタミン酸グリセリン、モノス
テアリン酸グリセリンリンゴ酸等のグリセリンポリグリ
セリン脂肪酸類、モノステアリン酸プロピレングリコー
ル等のプロピレングリコール脂肪酸エステル類、硬化ヒ
マシ油誘導体、グリセリンアルキルエーテル、ポリオキ
シエチレン・メチルポリシロキサン共重合体等が挙げら
れる。Examples of lipophilic nonionic surfactants include sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate, sorbitan trioleate, Penta-2-ethylhexylate diglycerol sorbitan, tetra-2-ethylhexylate diglycerol sorbitan, and other sorbitan fatty acid esters, monocotton oil fatty acid glycerin, glyceryl monoerucate, glycerin sesquioleate, glyceryl monostearate, α,
α'-Glycerin oleoyl pyroglutamate, glycerin monostearate Glycerin polyglycerin fatty acids such as malic acid, propylene glycol fatty acid esters such as propylene glycol monostearate, hydrogenated castor oil derivative, glycerin alkyl ether, polyoxyethylene methyl Examples thereof include polysiloxane copolymers.
【0056】親水性非イオン界面活性剤としては、例え
ば、POEソルビタンモノオレエート、POE−ソルビ
タンモノステアレート、POE−ソルビタンモノオレエ
ート、POE−ソルビタンテトラオレエート等のPOE
ソルビタン脂肪酸エステル類、POE−ソルビットモノ
ラウレート、POE−ソルビットモノオレエート、PO
E−ソルビットペンタオレエート、POE−ソルビット
モノステアレート等のPOEソルビット脂肪酸エステル
類、POE−グリセリンモノステアレート、POE−グ
リセリンモノイソステアレート、POE−グリセリント
リイソステアレート等のPOEグリセリン脂肪酸エステ
ル類、POEモノオレエート、POEジステアレート、
POEモノジオレエート、システアリン酸エチレングリ
コール等のPOE脂肪酸エステル類、POEラウリルエ
ーテル、POEオレイルエーテル、POEステアリルエ
ーテル、POEベヘニルエーテル、POE2−オクチル
ドデシルエーテル、POEコレスタノールエーテル等の
POEアルキルエーテル類、POEオクチルフェニルエ
ーテル、POEノニルフェニルエーテル、POEジノニ
ルフェニルエーテル等のPOEアルキルフェニルエーテ
ル類、プルロニック等のプルアロニック型類、POE・
POPセチルエーテル、POE・POP2−デシルテト
ラデシルエーテル、POE・POPモノブチルエーテ
ル、POE・POP水添ラノリン、POE・POPグリ
セリンエーテル等のPOE・POPアルキルエーテル
類、テトロニック等のテトラPOE・テトラPOPエチ
レンジアミン縮合物類、POEヒマシ油、POE硬化ヒ
マシ油、POE硬化ヒマシ油モノイソステアレート、
POE硬化ヒマシ油トリイソステアレート、POE硬化
ヒマシ油モノピログルタミン酸モノイソステアリン酸ジ
エステル、POE硬化ヒマシ油マレイン酸等のPOEヒ
マシ油硬化ヒマシ油誘導体、POEソルビットミツロウ
等のPOEミツロウ・ラノリン誘導体、ヤシ油脂肪酸ジ
エタノールアミド、ラウリン酸モノエタノールアミド、
脂肪酸イソプロパノールアミド等のアルカノールアミ
ド、POEプロピレングリコール脂肪酸エステル、PO
Eアルキルアミン、POE脂肪酸アミド、ショ糖脂肪酸
エステル、POEノニルフェニルホルムアルデヒド縮合
物、アルキルエトキシジメチルアミンオキシド、トリオ
レイルリン酸等が挙げられる。Examples of the hydrophilic nonionic surfactant include POE sorbitan monooleate, POE-sorbitan monostearate, POE-sorbitan monooleate, POE-sorbitan tetraoleate and the like.
Sorbitan fatty acid esters, POE-sorbit monolaurate, POE-sorbit monooleate, PO
POE sorbit fatty acid esters such as E-sorbit pentaoleate and POE-sorbit monostearate, POE glycerin fatty acid esters such as POE-glycerin monostearate, POE-glycerin monoisostearate and POE-glycerin triisostearate , POE monooleate, POE distearate,
POE monodiolate, POE fatty acid esters such as ethylene glycol distearate, POE lauryl ether, POE oleyl ether, POE stearyl ether, POE behenyl ether, POE 2-octyldodecyl ether, POE alkyl ethers such as POE cholestanol ether, POE octyl POE alkyl phenyl ethers such as phenyl ether, POE nonyl phenyl ether, POE dinonyl phenyl ether, Pluronic type such as Pluronic, POE
POE / POP alkyl ethers such as POP cetyl ether, POE / POP 2-decyl tetradecyl ether, POE / POP monobutyl ether, POE / POP hydrogenated lanolin, POE / POP glycerin ether, and tetraPOE / tetraPOP ethylenediamine such as Tetronic Condensates, POE castor oil, POE hydrogenated castor oil, POE hydrogenated castor oil monoisostearate,
POE hydrogenated castor oil triisostearate, POE hydrogenated castor oil monopyroglutamic acid monoisostearate diester, POE hydrogenated castor oil POE castor oil hydrogenated castor oil derivative such as maleic acid, POE beeswax lanolin derivative such as POE sorbit beeswax, coconut oil Fatty acid diethanolamide, lauric acid monoethanolamide,
Alkanol amides such as fatty acid isopropanolamide, POE propylene glycol fatty acid ester, PO
Examples thereof include E alkylamine, POE fatty acid amide, sucrose fatty acid ester, POE nonylphenylformaldehyde condensate, alkylethoxydimethylamine oxide, and trioleylphosphoric acid.
【0057】その他、エチルパラベン,プチルパラベン
等の防腐剤、グリチルリチン酸誘導体,グリチルレチン
酸誘導体,サリチル酸誘導体,ヒノキチオール,酸化亜
鉛,アラントイン等の消炎剤、胎盤抽出物,グルタチオ
ン,ユキノシタ抽出物等の美白剤、シコン,バーチ,セ
ージ,ビワ, アロエ, アイリス,ブドウ,ヨクイニ
ン,ヘチマ,ユリ,サフラン,センキュウ,ショウキョ
ウ, オノニス, ニンニク, ヤナギ、トウキ等の抽出
物、メントール、カンファーなどの清涼剤、ローヤルゼ
リー,ATP、感光素,コレステロール誘導体,幼牛血
液抽出物等の賦活剤、ノニル酸ワレニルアミド,ニコチ
ン酸ベンジルエステル,ニコチン酸β−ブトキシエチル
エステル,カプサイシン,ジンゲロン,カンタリスチン
キ,イクタモール, タンニン酸,α−ポルネオール,
ニコチン酸トコフェロール,イノシトールヘキサニコチ
ネート,シクランデレート,シンナリジン,トラゾリ
ン,アセチルコリン,ベラパミル,セファランチン,γ
−オリザノール等の血行促進剤、硫黄,チアントール等
の抗脂漏剤がある。In addition, antiseptics such as ethylparaben and pentylparaben, glycyrrhizic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, anti-inflammatory agents such as hinokitiol, zinc oxide, and allantoin, placenta extract, glutathione, Yukinoshita extract and other whitening agents. , Shikon, birch, sage, loquat, aloe, iris, grape, yokinin, loofah, lily, saffron, senkyu, ginger, onionis, garlic, willow, extracts such as Japanese lantern, cooling agents such as menthol, camphor, royal jelly, ATP, photosensitizer, cholesterol derivative, activator such as calf blood extract, nonyl acid warenylamide, nicotinic acid benzyl ester, nicotinic acid β-butoxyethyl ester, capsaicin, zingerone, cantharisin tincture, ictamol, ta Nin acid, α- Poruneoru,
Tocopherol nicotinate, inositol hexanicotinate, cyclanderate, cinnarizine, trazoline, acetylcholine, verapamil, cepharanthin, γ
-There are blood circulation promoters such as oryzanol and antiseborrheic agents such as sulfur and thiantol.
【0058】天然の水溶性高分子としては、例えば、ア
ラビアガム,トラガカントガム,ガラクタン,グアガ
ム,キャロブガム,カラヤガム,カラギーナン,ペクチ
ン,カンテン,クインスシード(マルメロ),アルゲコ
ロイド(カッソウエキス),デンプン(コメ,トウモロ
コシ,バレイショ,コムギ),グリチルリチン酸等の植
物系高分子、キサンタンガム,デキストラン,サクシノ
グルカン,プルラン等の微生物系高分子、コラーゲン,
カゼイン,アルブミン,ゼラチン等の動物系高分子が挙
げられる。Examples of natural water-soluble polymers include gum arabic, tragacanth gum, galactan, guar gum, carob gum, karaya gum, carrageenan, pectin, agar, quince seeds (quince), algecoloids (cassius extract), starches (rice, corn). , Potato, wheat), plant-based polymers such as glycyrrhizic acid, microbial-based polymers such as xanthan gum, dextran, succinoglucan, pullulan, collagen,
Animal-based macromolecules such as casein, albumin and gelatin can be mentioned.
【0059】半合成の水溶性高分子としては、例えば、
カルボキシメチルデンプン,メチルヒドロキシプロピル
デンプン等のデンプン系高分子、メチルセルロース,ニ
トロセルロース,エチルセルロース,メチルヒドロキシ
プロピルセルロース,ヒドロキシエチルセルロース,セ
ルロース硫酸ナトリウム,ヒドロキシプロピルセルロー
ス,カルボキシメチルセルロースナトリウム(CM
C),結晶セルロース,セルロース末等のセルロース系
高分子、アルギン酸ナトリウム,アルギン酸プロピレン
グリコールエステル等のアルギン酸系高分子が挙げられ
る。As the semi-synthetic water-soluble polymer, for example,
Starch-based polymers such as carboxymethyl starch and methyl hydroxypropyl starch, methyl cellulose, nitrocellulose, ethyl cellulose, methyl hydroxypropyl cellulose, hydroxyethyl cellulose, sodium cellulose sulfate, hydroxypropyl cellulose, sodium carboxymethyl cellulose (CM
C), crystalline cellulose, cellulose-based polymers such as cellulose powder, and alginic acid-based polymers such as sodium alginate and propylene glycol alginate.
【0060】合成の水溶性高分子としては、例えば、ポ
リビニルアルコール,ポリビニルメチルエーテル,ポリ
ビニルピロリドン,カルボキシビニルポリマー(カーボ
ポール)等のビニル系高分子、ポリエチレングリコール
2,000,4,000,6,000等のポリオキシエチレン系高分
子、ポリオキシエチレンポリオキシプロピレン共重合体
等の共重合系高分子、ポリアクリル酸ナトリウム,ポリ
エチルアクリレート,ポリアクリルアミド等のアクリル
系高分子、ポリエチレンイミン、カチオンポリマー等が
挙げられる。Examples of the synthetic water-soluble polymer include polyvinyl alcohol, polyvinyl methyl ether, polyvinylpyrrolidone, vinyl polymers such as carboxyvinyl polymer (Carbopol), and polyethylene glycol.
Polyoxyethylene polymers such as 2,000, 4,000, 6,000, copolymers such as polyoxyethylene polyoxypropylene copolymer, acrylic polymers such as sodium polyacrylate, polyethyl acrylate, polyacrylamide, polyethylene Examples include imines and cationic polymers.
【0061】無機の水溶性高分子としては、例えば、ベ
ントナイト、ケイ酸AlMg(ビーガム)、ラポナイ
ト、へクトライト、無水ケイ酸等が挙げられる。Examples of the inorganic water-soluble polymer include bentonite, AlMg silicate (veegum), laponite, hectorite, and silicic acid anhydride.
【0062】増粘剤としては、例えばアラビアガム、カ
ラギーナン、カラヤガム、トラガカントガム、キャロブ
ガム、クインスシード(マルメロ)、カゼイン、デキス
トリン、ゼラチン、ペクチン酸ナトリウム、アラギン酸
ナトリウム、メチルセルロース、エチルセルロース、C
MC、ヒドロキシエチルセルロース、ヒドロキシプロピ
ルセルロース、PVA、PVM、PVP、ポリアクリル
酸ナトリウム、カルボキシビニルポリマー、ローカスト
ビーンガム、グアーガム、タマリントガム、ジアルキル
ジメチルアンモニウム硫酸セルロース、キサンタンガ
ム、ケイ酸アルミニウムマグネシウム、ベントナイト、
ヘクトライト等が挙げられる。Examples of the thickener include gum arabic, carrageenan, karaya gum, tragacanth gum, carob gum, quince seed (quince), casein, dextrin, gelatin, sodium pectate, sodium alginate, methyl cellulose, ethyl cellulose, C
MC, hydroxyethyl cellulose, hydroxypropyl cellulose, PVA, PVM, PVP, sodium polyacrylate, carboxyvinyl polymer, locust bean gum, guar gum, tamarind gum, dialkyldimethylammonium sulfate cellulose, xanthan gum, magnesium aluminum silicate, bentonite,
Hectorite and the like can be mentioned.
【0063】粉末成分としては、タルク,カオリン,雲
母,絹雲母(セリサイト),白雲母,金雲母,合成雲
母,紅雲母,黒雲母,リチア雲母,バーミキュライト,
炭酸マグネシウム,炭酸カルシウム,ケイ酸アルミニウ
ム,ケイ酸バリウム,ケイ酸カルシウム,ケイ酸マグネ
シウム,ケイ酸ストロンチウム,タングステン酸金属
塩,マグネシウム,シリカ,ゼオライト,硫酸バリウ
ム,焼成硫酸カルシウム(焼セッコウ),リン酸カルシ
ウム,弗素アパタイト,ヒドロキシアパタイト,セラミ
ックパウダー,金属石鹸(ミリスチン酸亜鉛,パルミチ
ン酸カルシウム,ステアリン酸アルミニウム),窒化ホ
ウ素等の無機粉末、ポリアミド樹脂粉末(ナイロン粉
末),ポリエチレン粉末,ポリメタクリル酸メチル粉
末,ポリスチレン粉末,スチレンとアクリル酸の共重合
体樹脂粉末,ベンゾグアナミン樹脂粉末,ポリ四弗化エ
チレン粉末,セルロース粉末等の有機粉末、二酸化チタ
ン,酸化亜鉛等の無機白色顔料、酸化鉄(ベンガラ),
チタン酸鉄等の無機赤色系顔料、γ−酸化鉄等の無機褐
色系顔料、黄酸化鉄,黄土等の無機黄色系顔料、黒酸化
鉄,カーボンブラック,低次酸化チタン等の無機黒色系
顔料、マンゴバイオレット,コバルトバイオレット等の
無機紫色系顔料、酸化クロム,水酸化クロム,チタン酸
コバルト等の無機緑色系顔料、群青,紺青等の無機青色
系顔料、酸化チタンコーテッドマイカ,酸化チタンコー
テッドオキシ塩化ビスマス,酸化チタンコーテッドタル
ク,着色酸化チタンコーテッドマイカ,オキシ塩化ビス
マス,魚鱗箔等のパール顔料,アルミニウムパウダー,
カッパーパウダー等の金属粉末顔料、赤色201号,赤色2
02号,赤色204号,赤色205号,赤色220号,赤色226号,
赤色228号,赤色405号,鐙色203号,燈登色204号,黄色
205号,黄色401号,青色404号などの有機顔料、赤色3
号,赤色104号,赤色106号,赤色227号,赤色230号,赤
色401号,赤色505号,橿登色205号,黄色4号,黄色5
号,黄色202号,黄色203号,緑色3号,青色1号などのジ
ルコニウム、バリウム又はアルミニウムレーキ等の有機
顔料、クロロフィル,リボフラビン、クロシン、アント
ラキノン、β−カロチン等の天然色素等、香料、水、ア
ルコール、チタンイエロー,カーサミン,紅花赤等の色
剤、等を必要に応じて適宜配合ができる。As powder components, talc, kaolin, mica, sericite, muscovite, phlogopite, synthetic mica, phlogopite, biotite, lithia mica, vermiculite,
Magnesium carbonate, calcium carbonate, aluminum silicate, barium silicate, calcium silicate, magnesium silicate, strontium silicate, tungstate metal salt, magnesium, silica, zeolite, barium sulfate, calcined calcium sulfate (calculated gypsum), calcium phosphate, Fluorapatite, hydroxyapatite, ceramic powder, metallic soap (zinc myristate, calcium palmitate, aluminum stearate), inorganic powder such as boron nitride, polyamide resin powder (nylon powder), polyethylene powder, polymethylmethacrylate powder, polystyrene Powder, styrene-acrylic acid copolymer resin powder, benzoguanamine resin powder, polytetrafluoroethylene powder, organic powder such as cellulose powder, inorganic white such as titanium dioxide and zinc oxide Fee, iron oxide (red iron oxide),
Inorganic red pigments such as iron titanate, inorganic brown pigments such as γ-iron oxide, inorganic yellow pigments such as yellow iron oxide and ocher, and inorganic black pigments such as black iron oxide, carbon black, and lower titanium oxide. , Mango Violet, Cobalt Violet and other inorganic purple pigments, Chromium oxide, Chromium hydroxide, Cobalt titanate and other inorganic green pigments, Ultramarine blue, Navy blue and other inorganic blue pigments, Titanium oxide coated mica, Titanium oxide coated oxychloride Bismuth, titanium oxide coated talc, colored titanium oxide coated mica, bismuth oxychloride, pearl pigments such as fish scale foil, aluminum powder,
Metal powder pigments such as copper powder, Red No. 201, Red 2
02, red 204, red 205, red 220, red 226,
Red 228, Red 405, Stirrup 203, Lanting 204, Yellow
205, Yellow 401, Blue 404 and other organic pigments, Red 3
No., Red No. 104, Red No. 106, Red No. 227, Red No. 230, Red No. 401, Red No. 505, Kashi Nobori No. 205, Yellow No. 4, Yellow No. 5
No., Yellow No. 202, Yellow No. 203, Green No. 3, Blue No. 1, etc., organic pigments such as zirconium, barium or aluminum lake, natural pigments such as chlorophyll, riboflavin, crocin, anthraquinone, β-carotene, fragrance, water , Alcohol, titanium yellow, cursamine, safflower red, and other coloring agents can be appropriately blended as necessary.
【0064】また、本発明の皮膚外用剤の剤型は任意で
あり、例えば油状製剤、化粧水系の可溶化系、乳液、ク
リーム等の乳化系あるいはジェル、ペースト、パック、
プラスター、シート、軟膏、分散液、粉末等の剤型をと
ることができる。The external preparation for skin according to the present invention may have any dosage form, for example, an oily preparation, a solubilizing system for lotion, an emulsion system such as emulsion or cream, or a gel, paste, pack,
Dosage forms such as plasters, sheets, ointments, dispersions and powders can be used.
【0065】[0065]
【実施例】次に実施例により本発明をさらに詳細に説明
する。なお、本発明はこれらの実施例により限定される
ものではない。配合量は重量%である。実施例に先立
ち、本発明の効果を実験データによって示す。EXAMPLES The present invention will be described in more detail with reference to examples. The present invention is not limited to these examples. The blending amount is% by weight. Prior to the examples, the effect of the present invention is shown by experimental data.
【0066】1.植物抽出物の調製
キョウニン(アンズ種子乾燥物)1000gを水300
0mlにより90〜95℃、2時間加熱抽出し、抽出液
を濾過後、減圧濃縮して300g(乾燥物換算:25
g)のキョウニン熱水抽出物を得た。また、キョウニン
(アンズ種子乾燥物)1000gをエタノール3000
mlにより90〜95℃、2時間加熱抽出し、抽出液を
濾過後、減圧濃縮して、300g(乾燥物換算:40
g)のキョウニンエタノール抽出物を得た。そのほかの
植物についても同様の操作で抽出物を得た。1. Preparation of plant extract 1000 g of Kyonin (apricot seed dry matter) in 300 parts of water
It is heated and extracted with 0 ml at 90 to 95 ° C. for 2 hours, the extract is filtered, and then concentrated under reduced pressure to 300 g (dry matter conversion: 25
g) hot water extract of Kyounin was obtained. Also, 1,000 g of Kyounin (dried apricot seeds) was added to ethanol 3000.
90 ml to 90 ° C. for 2 hours, and the extract is filtered and concentrated under reduced pressure to give 300 g (dry matter conversion: 40
g) Kyonin ethanol extract was obtained. Extracts were obtained from other plants by the same procedure.
【0067】実験例1 脂質分解効果
[評価方法]脂肪組織からの脂肪細胞の単離は、Rodbel
lの方法(M.Rodbell,J.B.C.,239(2).1964)に準じ
た。脂肪吸引にて得られたヒトの脂肪組織より調製した
脂肪細胞50μlを、2.5%牛血清アルブミンを含む
ハンクス緩衝液200μlと表1に示すサンプル25μ
lの混合溶液に加え、37度で1時間インキュベートし
た。各サンプル中、抽出物濃度は合計で10%とし、2
種類の薬剤を用いた時の抽出物との割合は1:1とし
た。キサンチン誘導体、エスクロシド、ベルベリンにつ
いては0.02mg/mlとした。反応液にクロロホル
ム:ヘプタン:メタノール(98:98:4)3mlを
加えて撹拌し、脂質を抽出した。水層を吸引除去した
後、Duncombeの方法(Biochemical Journal,88(7),19
63)に従って遊離脂肪酸量(μmol/ml packed cells/
h)を測定し、分解脂質量とした。その実験結果を表1〜
表2に示す。なお参考例として、脂質分解促進剤として
従来公知であるノルエピネフリン(ノルアドレナリン)
(0.05μg/ml)について測定した結果も併せて表1に示
す。Experimental Example 1 Lipolytic effect [Evaluation method] Adipocytes were isolated from adipose tissue by Rodbel
1 method (M. Rodbell, JBC, 239 (2) .1964). 50 μl of adipocytes prepared from human adipose tissue obtained by liposuction was mixed with 200 μl of Hanks buffer containing 2.5% bovine serum albumin and 25 μl of the sample shown in Table 1.
1 of the mixed solution and incubated at 37 ° C. for 1 hour. The total extract concentration in each sample was 10%, and 2
The ratio with the extract when using one kind of drug was set to 1: 1. The xanthine derivative, escroside, and berberine were 0.02 mg / ml. 3 ml of chloroform: heptane: methanol (98: 98: 4) was added to the reaction solution, and the mixture was stirred to extract lipids. After removing the aqueous layer by suction, the method of Duncombe (Biochemical Journal, 88 (7), 19
63) Free fatty acid amount (μmol / ml packed cells /
h) was measured and used as the amount of degraded lipid. The experimental results are shown in Table 1
It shows in Table 2. As a reference example, norepinephrine (noradrenaline), which is conventionally known as a lipid decomposition accelerator, is used.
The results of measurement for (0.05 μg / ml) are also shown in Table 1.
【0068】[0068]
【表1】 ──────────────────────────────── サンプル 分解脂質量 (μmol/ml packed cells/h) ──────────────────────────────── 未添加 0.10±0.02 ノルエピネフリン(0.05μg/ml) 8.5±0.3 キョウニン熱水抽出物 11.2±0.4 キョウニンエタノール抽出物 10.5±0.3 シャクヤク熱水抽出物 11.3±0.4 トウニン熱水抽出物 10.4±0.3 ブクリョウエタノール抽出物 13.6±0.3 キキョウ1.3BG抽出物 12.7±0.3 ケイカイエタノール抽出物 12.4±0.3 ケイシ1.3BG抽出物 12.9±0.2 チョレイエタノール抽出物 13.4±0.5 ビャクジュツ熱水抽出物 11.9±0.3 ジオウ熱水抽出物 14.2±0.4 センキュウエタノール抽出物 15.1±0.2 タイソウ熱水抽出物 11.8±0.2 トウキエタノール抽出物 13.2±0.3 バクモンドウ熱水抽出物 12.5±0.4 ハッカ熱水抽出物 12.4±0.4 タクシャ1.3BG抽出物 12.3±0.4 ボウフウエタノール抽出物 13.3±0.3 サンシュユ熱水抽出物 15.9±0.3 ────────────────────────────────[Table 1] ──────────────────────────────── Sample Degraded lipid amount (Μmol / ml packed cells / h) ──────────────────────────────── Not added 0.10 ± 0.02 Norepinephrine (0.05 μg / ml) 8.5 ± 0.3 Kyounin hot water extract 11.2 ± 0.4 Kyounin ethanol extract 10.5 ± 0.3 Peony hot water extract 11.3 ± 0.4 Tonin hot water extract 10.4 ± 0.3 Bukuryo ethanol extract 13.6 ± 0.3 Kyoukyo 1.3BG extract 12.7 ± 0.3 Keikai ethanol extract 12.4 ± 0.3 Keishi 1.3BG extract 12.9 ± 0.2 Chorei ethanol extract 13.4 ± 0.5 Sandalwood hot water extract 11.9 ± 0.3 Geothermal hot water extract 14.2 ± 0.4 Gypsophila ethanol extract 15.1 ± 0.2 Thai Sou hot water extract 11.8 ± 0.2 Touki ethanol extract 13.2 ± 0.3 Bakmondou hot water extract 12.5 ± 0.4 Mint hot water extract 12.4 ± 0.4 Takusha 1.3BG extract 12.3 ± 0.4 Bowfu ethanol extract 13.3 ± 0.3 Sansuyu hot water extract 15.9 ± 0.3 ────────────────────────────────
【0069】[0069]
【表2】 ────────────────────────────────── サンプル 分解脂質量 (μmol/ml packed cells/h) ────────────────────────────────── キョウニン熱水抽出物+ジオウ熱水抽出物 17.1±0.4 キョウニンエタノール抽出物+トウキエタノール抽出物 16.5±0.4 シャクヤク熱水抽出物+ハッカ抽出物+ボウフウ抽出物 18.3±0.5 トウニン熱水抽出物+ブクリョウエタノール抽出物 16.6±0.5 ──────────────────────────────────[Table 2] ────────────────────────────────── Sample Degraded lipid amount (Μmol / ml packed cells / h) ────────────────────────────────── Kyounin hot water extract + Zyou hot water extract 17.1 ± 0.4 Kyounin ethanol extract + Touki ethanol extract 16.5 ± 0.4 Peony Peony Hot Water Extract + Mint Extract + Bowfu Extract 18.3 ± 0.5 Tonin hot water extract + Bukuryo ethanol extract 16.6 ± 0.5 ──────────────────────────────────
【0070】表1〜表2から、キョウニン、シャクヤ
ク、トウニン、ブクリョウ、キキョウ、ケイカイ、ケイ
シ、チョレイ、ビャクジュツ、ジオウ、センキュウ、タ
イソウ、トウキ、バクモンドウ、ハッカ、タクシャ、ボ
ウフウおよびサンシュユ抽出物は脂質分解を促進し、2
種以上の組み合わせによりさらに脂質分解が促進される
ことがわかる。From Tables 1 and 2, Kyonin, Peonies, Tounin, Bukuryo, Kyoukyo, Keikai, Keishi, Chorei, Juniper, Diou, Senkyuu, Taiso, Touki, Bakumondou, Mint, Takusha, Boufu and Sanshuyu extracts are lipid-decomposed. Promote 2
It can be seen that the combination of two or more species further promotes lipolysis.
【0071】
実施例1 ボディー用美容液
(1)タイソウ抽出物 5.0 重量%
(2)サンシュユ抽出物 3.0
(3)グリシン 1.0
(4)ヒアルロン酸ナトリウム 0.01
(5)グリセリン 10.0
(6)1,3−ブチレングリコール 5.0
(7)カルボキシビニルポリマー 0.3
(8)エタノール 7.0
(9)ポリオキシエチレン(18)
オレイルアルコールエーテル 0.8
(10)マカデミアナッツ油 0.5
(11)ポリビニルアルコール 2.0
(12)酢酸トコフェロール 0.01
(13)メチルパラベン 0.15
(14)香料 0.1
(15)メントール 0.5
(16)水酸化カリウム 0.08
(17)精製水 残余
(製法)(17)に(1)〜(7)を溶解し、別に(8)に
(9)〜(15)を溶解したものを添加する。その後(1
6)を添加して、ボディー用美容液を得た。Example 1 Serum for Body (1) Phellinus linteus extract 5.0% by weight (2) Sanshuyu extract 3.0 (3) Glycine 1.0 (4) Sodium hyaluronate 0.01 (5) Glycerin 10.0 (6) 1,3-Butylene glycol 5.0 (7) Carboxyvinyl polymer 0.3 (8) Ethanol 7.0 (9) Polyoxyethylene (18) Oleyl alcohol ether 0.8 (10) Macadamia nuts Oil 0.5 (11) Polyvinyl alcohol 2.0 (12) Tocopherol acetate 0.01 (13) Methylparaben 0.15 (14) Perfume 0.1 (15) Menthol 0.5 (16) Potassium hydroxide 0.08 (17) Purified water Dissolve (1) to (7) in the residue (production method) (17), and separately add (9) to (15) in (8). Then (1
6) was added to obtain a body serum.
【0072】比較例1 ボディー用美容液
実施例1においてタイソウ抽出物、サンシュユ抽出物を
精製水に置き換えた他は実施例1と同様にしてボディー
用美容液を調製した。Comparative Example 1 Body Serum A body essence was prepared in the same manner as in Example 1 except that the pearl millet extract and the saury extract were replaced with purified water.
【0073】実験例2 ヒトによる効果試験
[評価方法]20〜40代女性40人ずつに前記実施例
1および比較例1の処方のボディー用美容液を全身に朝
晩塗布してもらい、1ヵ月連用してもらった。連用前後
の体重および体脂肪率(体全体に対する脂肪の割合)を
生体インピーダンス測定を原理とする測定器(体重計付
き体脂肪計、タニタ社製)により測定した。使用前、使
用後の体重および体脂肪率の平均値を求めた。その結果
を表3に示す。Experimental Example 2 Effect test by human [Evaluation method] Forty women in their 20s to 40s were asked to apply the body beauty essences of the formulations of Example 1 and Comparative Example 1 to the whole body in the morning and evening, and they were continuously used for 1 month. I was asked to. The body weight and body fat percentage (ratio of fat to the whole body) before and after continuous use were measured by a measuring device (body fat meter with a weight scale, manufactured by Tanita) based on the principle of bioimpedance measurement. The average values of body weight and body fat percentage before and after use were obtained. The results are shown in Table 3.
【0074】[0074]
【表3】 ─────────────────────────────────── 実施例1 比較例1 ──────────── ────────────── 連用前 1ヶ月連用後 連用前 1ヶ月連用後 ─────────────────────────────────── 体重(kg) 63.2±1.2 60.5±1.1 63.0±1.1 63.3±1.2 体脂肪率(%) 35.1±0.8 31.4±0.9 34.1±0.6 33.8±0.9 ───────────────────────────────────[Table 3] ─────────────────────────────────── Example 1 Comparative example 1 ────────────────────────── Before continuous use 1 month after continuous use Before continuous 1 month after continuous use ─────────────────────────────────── Weight (kg) 63.2 ± 1.2 60.5 ± 1.1 63.0 ± 1.1 63.3 ± 1.2 Body fat percentage (%) 35.1 ± 0.8 31.4 ± 0.9 34.1 ± 0.6 33.8 ± 0.9 ───────────────────────────────────
【0075】上記の結果より明らかなように、本発明品
である実施例1を用いた場合は、使用前に比べて体重お
よび体脂肪率の減少が顕著になっているが、比較例1で
はほとんど減少がみられなかった。As is clear from the above results, when Example 1 which is the product of the present invention is used, the decrease in body weight and body fat percentage is remarkable as compared with before use, but in Comparative Example 1, Almost no decrease was seen.
【0076】
実施例2 化粧水
(1)キョウニン抽出物 30.0 重量%
(2)メントール 0.5
(3)グリセリン 4.0
(4)1,3−ブチレングリコール 4.0
(5)酢酸トコフェロール 0.05
(6)エタノール 7.0
(7)ポリオキシエチレン(18)
オレイルアルコールエーテル 0.5
(8)メチルパラベン 0.2
(9)クエン酸 0.05
(10)クエン酸ナトリウム 0.1
(11)香料 0.05
(12)精製水 残余
(製法)精製水にクエン酸、クエン酸ナトリウム、グリ
セリン、1,3−ブチレングリコール、キョウニン抽出
物を溶解する(水相)。別にエタノールにポリオキシエ
チレンオレイルアルコールエーテル、酢酸トコフェロー
ル、香料、メチルパラベン、メントールを溶解し、これ
を前述の水相に加えて可溶化し、濾過して化粧水を得
た。Example 2 Lotion (1) Kyounin extract 30.0% by weight (2) Menthol 0.5 (3) Glycerin 4.0 (4) 1,3-Butylene glycol 4.0 (5) Tocopherol acetate 0.05 (6) Ethanol 7.0 (7) Polyoxyethylene (18) Oleyl alcohol ether 0.5 (8) Methylparaben 0.2 (9) Citric acid 0.05 (10) Sodium citrate 0.1 ( 11) Fragrance 0.05 (12) Purified water Citric acid, sodium citrate, glycerin, 1,3-butylene glycol, and Kyounin extract are dissolved in the remaining (manufacturing method) purified water (aqueous phase). Separately, polyoxyethylene oleyl alcohol ether, tocopherol acetate, fragrance, methylparaben, and menthol were dissolved in ethanol, and this was added to the above aqueous phase to solubilize it, followed by filtration to obtain a lotion.
【0077】比較例2 化粧水
実施例2においてキョウニン抽出物を精製水に置き換え
た他は実施例2と同様にして化粧水を調製した。Comparative Example 2 Lotion A lotion was prepared in the same manner as in Example 2 except that the Kyounin extract was replaced with purified water.
【0078】
実施例3 クリーム
(1)セトステアリルアルコール 3.5 重量%
(2)スクワラン 40.0
(3)ミツロウ 3.0
(4)還元ラノリン 5.0
(5)エチルパラベン 0.3
(6)ポリオキシエチレン(20)
ソルビタンモノパルミチン酸エステル 2.0
(7)ステアリン酸モノグリセリド 2.0
(8)N−ステアロイルグルタミン酸ナトリウム 0.5
(9)2−ヒドロキシ−4−メトキシベンゾフェノン 1.0
(10)酢酸レチノール 2.0
(11)月見草油 0.05
(12)香料 0.05
(13)チョレイ抽出物 0.01
(14)ポリアクリル酸アミド 0.5
(15)バクモンドウ抽出物 5.0
(16)1,3−ブチレングリコール 1.5
(17)精製水 残余
(製法)(1)〜(12)を加熱溶解し、70℃に加温し
た(13)〜(17)に攪拌しながら加える。ホモミキサー
処理し、乳化粒子を細かくした後、攪拌しながら急冷
し、クリームを得た。Example 3 Cream (1) Cetostearyl alcohol 3.5% by weight (2) Squalane 40.0 (3) Beeswax 3.0 (4) Reduced lanolin 5.0 (5) Ethylparaben 0.3 (6 ) Polyoxyethylene (20) sorbitan monopalmitic acid ester 2.0 (7) stearic acid monoglyceride 2.0 (8) sodium N-stearoyl glutamate 0.5 (9) 2-hydroxy-4-methoxybenzophenone 1.0 ( 10) Retinol acetate 2.0 (11) Evening primrose oil 0.05 (12) Fragrance 0.05 (13) Chorei extract 0.01 (14) Polyacrylic acid amide 0.5 (15) Bakumondou extract 5.0 (16) 1,3-Butylene glycol 1.5 (17) Purified water The residue (production method) (1) to (12) was dissolved by heating, and the mixture was stirred at (13) to (17) heated to 70 ° C. Want added. The mixture was treated with a homomixer to make the emulsified particles finer, and then rapidly cooled with stirring to obtain a cream.
【0079】比較例3 クリーム
実施例3においてチョレイ抽出物およびバクモンドウ抽
出物を精製水に置き換えた他は実施例3と同様にしてク
リームを調製した。Comparative Example 3 Cream A cream was prepared in the same manner as in Example 3 except that the Chorei extract and Bakumondou extract were replaced with purified water.
【0080】
実施例4 乳液
(1)ステアリン酸 1.5 重量%
(2)セチルアルコール 0.5
(3)ミツロウ 2.0
(4)ポリオキシエチレン(10)
モノオレイン酸エステル 1.0
(5)メトキシケイ皮酸オクチル 2.0
(6)シャクヤク抽出物 1.0
(7)トウニン抽出物 1.0
(8)ボウフウ抽出物 1.0
(9)ヒアルロン酸ナトリウム 0.01
(10)トリエタノールアミン 0.75
(11)グリセリン 7.0
(12)イノシット 0.5
(13)人参エキス 0.5
(14)エチルパラベン 0.3
(15)香料 0.03
(16)ポリビニルアルコール 1.0
(17)精製水 残余
(製法)精製水にシャクヤク抽出物、ボウフウ抽出物、
トウニン抽出物、ヒアルロン酸ナトリウム、グリセリ
ン、イノシット、人参エキス、カフェイン、トリエタノ
ールアミンを加えて70℃に保つ(水相)。ポリビニル
アルコールを一部の水に溶解して水相に加える。他の成
分を混合し、加熱溶解して70℃に保つ(油相)。水相
に油相を加えて予備乳化を行い、ホモミキサーで均一に
乳化する。その後攪拌しながら急冷して乳液を得た。Example 4 Emulsion (1) Stearic Acid 1.5 wt% (2) Cetyl Alcohol 0.5 (3) Beeswax 2.0 (4) Polyoxyethylene (10) Monooleate 1.0 (5) ) Octyl methoxycinnamate 2.0 (6) Peony extract 1.0 (7) Tonin extract 1.0 (8) Bofu extract 1.0 (9) Sodium hyaluronate 0.01 (10) Triethanol Amine 0.75 (11) Glycerin 7.0 (12) Inosit 0.5 (13) Ginseng extract 0.5 (14) Ethylparaben 0.3 (15) Perfume 0.03 (16) Polyvinyl alcohol 1.0 ( 17) Purified water Residue (manufacturing method) Purified water with peony extract, boufu extract,
Tonin extract, sodium hyaluronate, glycerin, inosit, ginseng extract, caffeine, and triethanolamine are added and kept at 70 ° C (aqueous phase). Polyvinyl alcohol is dissolved in some water and added to the aqueous phase. The other ingredients are mixed, dissolved by heating and kept at 70 ° C. (oil phase). The oil phase is added to the aqueous phase for preliminary emulsification, and the mixture is homogenized with a homomixer. Then, it was rapidly cooled with stirring to obtain an emulsion.
【0081】比較例4 乳液
実施例4においてシャクヤク抽出物、ボウフウ抽出物お
よびトウニン抽出物を精製水に置き換えた他は実施例4
と同様にして乳液を調製した。COMPARATIVE EXAMPLE 4 Emulsion Example 4 except that the peony extract, the Bofufu extract and the Tounin extract in Example 4 were replaced with purified water.
An emulsion was prepared in the same manner as in.
【0082】
実施例5 フォームパック
(1)ブクリョウ抽出物 10.0 重量%
(2)キキョウ抽出物 10.0
(3)1,3−ブチレングリコール 5.0
(4)グリセリン 7.0
(5)メチルパラベン 0.1
(6)水酸化カリウム 0.15
(7)ステアリン酸 0.5
(8)ミリスチン酸 1.0
(9)バチルアルコール 1.5
(10)ポリオキシエチレン(60)硬化ヒマシ油 3.0
(11)香料 0.05
(12)液化石油ガス 6.0
(13)ジメチルエーテル 3.0
(14)精製水 残余
(製法)(14)に(1)〜(6)を加えて70℃で加熱溶
解し、その中に(7)〜(11)を75℃に加熱攪拌した
ものを加え、十分に攪拌した後、冷却する。これを容器
に充填し、最後に(12)、(13)を噴射剤として充填
し、フォームパックを得た。Example 5 Foam pack (1) Bukyou extract 10.0% by weight (2) Cypress extract 10.0 (3) 1,3-butylene glycol 5.0 (4) Glycerin 7.0 (5) Methylparaben 0.1 (6) Potassium hydroxide 0.15 (7) Stearic acid 0.5 (8) Myristic acid 1.0 (9) Batyl alcohol 1.5 (10) Polyoxyethylene (60) Hydrogenated castor oil 3 .0 (11) Perfume 0.05 (12) Liquefied petroleum gas 6.0 (13) Dimethyl ether 3.0 (14) Purified water Residual (manufacturing method) (14) with (1) to (6) added to 70 ° C It is heated and dissolved in, and (7) to (11) are heated and stirred at 75 ° C, and the mixture is sufficiently stirred and then cooled. This was filled in a container, and finally (12) and (13) were filled as a propellant to obtain a foam pack.
【0083】
実施例6 軟膏
(1)ケイカイ抽出物 12.0 重量%
(2)タクシャエキス 1.0
(3)パルミチン酸レチノール 0.5
(4)ステアリルアルコール 18.0
(5)モクロウ 20.0
(6)ポリオキシエチレン(20)
モノオレイン酸エステル 0.25
(7)グリセリンモノステアリン酸エステル 0.3
(8)ワセリン 40.0
(9)精製水 残余
(製法)精製水にケイカイ抽出物、タクシャエキスを加
えて溶解し、70℃に保つ(水相)。残りの成分を70
℃にて混合溶解する(油相)。水相に油相を加え、ホモ
ミキサーで均一に乳化後、冷却して軟膏を得た。Example 6 Ointment (1) Keikai extract 12.0 wt% (2) Takusha extract 1.0 (3) Retinol palmitate 0.5 (4) Stearyl alcohol 18.0 (5) Mokurou 20.0 ( 6) Polyoxyethylene (20) Monooleic acid ester 0.25 (7) Glycerin monostearic acid ester 0.3 (8) Vaseline 40.0 (9) Purified water Residue (manufacturing method) Purified water with cabbage extract, Takusha extract Is added and dissolved, and the mixture is maintained at 70 ° C (aqueous phase). 70 remaining ingredients
Mix and dissolve at ℃ (oil phase). The oil phase was added to the aqueous phase, and the mixture was uniformly emulsified with a homomixer and then cooled to obtain an ointment.
【0084】
(製法)精製水にケイシ抽出物、ビャクジュツ抽出物、
ジオウ抽出物、グリセリン、1,3−ブチレングリコー
ル、トリエタノールアミンを加えて70℃に保つ(水
相)。他の成分を混合し、加熱溶解して70℃に保つ
(油相)。水相に油相を加えて予備乳化を行い、ホモミ
キサーで均一に乳化する。その後攪拌しながら急冷して
マッサージ用乳液を得た。[0084] (Manufacturing method) Purified water with cabbage extract, juniper extract,
The dio extract, glycerin, 1,3-butylene glycol, and triethanolamine are added and kept at 70 ° C. (aqueous phase). The other ingredients are mixed, dissolved by heating and kept at 70 ° C. (oil phase). The oil phase is added to the aqueous phase for preliminary emulsification, and the mixture is homogenized with a homomixer. Then, it was rapidly cooled with stirring to obtain a milky lotion for massage.
【0085】比較例5 マッサージ用乳液
実施例7においてケイシ抽出物、ビャクジュツ抽出物、
ジオウ抽出物を精製水に置き換えた他は実施例7と同様
にしてマッサージ用乳液を調製した。Comparative Example 5 Milky lotion for massage In Example 7, a cabbage extract, a juniper extract,
A milky lotion for massage was prepared in the same manner as in Example 7 except that the extract of Diou was replaced with purified water.
【0086】
実施例8 マッサージ用ジェル
(1)トウキ抽出物 0.5 重量%
(2)センキュウ抽出物 2.0
(3)ハッカ抽出物 1.0
(4)グリセリン 50.0
(5)カルボキシビニルポリマー 0.4
(6)ポリオキシエチレン(10)
メチルポリシロキサン共重合体 2.0
(7)スクワラン 1.0
(8)ポリエチレングリコール400 30.0
(9)アルギニン 0.24
(10)香料 0.15
(11)精製水 残余
(製法)精製水にトウキ抽出物、センキュウ抽出物、ハ
ッカ抽出物、グリセリン、ポリエチレングリコール40
0、カルボキシビニルポリマーを溶解する。別にスクワ
ラン、ポリオキシエチレン(10)メチルポリシロキサ
ン共重合体、香料を混合したものを添加した後、アルギ
ニンを加えて、マッサージ用ジェルを得た。Example 8 Gel for Massage (1) Touki Extract 0.5% by Weight (2) Gypsophila Extract 2.0 (3) Mint Extract 1.0 (4) Glycerin 50.0 (5) Carboxyvinyl Polymer 0.4 (6) Polyoxyethylene (10) Methyl polysiloxane copolymer 2.0 (7) Squalane 1.0 (8) Polyethylene glycol 400 30.0 (9) Arginine 0.24 (10) Perfume 0 .15 (11) Purified water Residue (manufacturing method) Purified water with Touki extract, Senkyu extract, mint extract, glycerin, polyethylene glycol 40
0, dissolve the carboxyvinyl polymer. Separately, a mixture of squalane, polyoxyethylene (10) methylpolysiloxane copolymer, and fragrance was added, and then arginine was added to obtain a massage gel.
【0087】比較例6 マッサージ用ジェル
実施例8においてトウキ抽出物、センキュウ抽出物、ハ
ッカ抽出物を精製水に置き換えた他は実施例8と同様に
してマッサージ用ジェルを調製した。Comparative Example 6 Massage Gel A massage gel was prepared in the same manner as in Example 8 except that purified water was used in place of the Touki extract, Senkyu extract and mint extract.
【0088】実験例3 使用試験
実施例1〜4、7、8および比較例1〜6の外用剤を用
いて、各々女性40人(20〜40代)を対象に1ヵ月
の使用試験を行った。使用後、(1)肌のひきしめ感、
(2)肌のはり、(3)肌の弾力感、(4)肌荒れ改善
効果に関するアンケート調査により痩身効果を判定し
た。その結果を表4および表5に示す。Experimental Example 3 Usage Test Using the external preparations of Examples 1 to 4, 7, 8 and Comparative Examples 1 to 6, 40 women (20 to 40 years old) were subjected to a usage test for 1 month. It was After use, (1) the tightness of the skin,
The slimming effect was determined by a questionnaire survey regarding (2) skin swelling, (3) skin elasticity, and (4) skin roughness improving effect. The results are shown in Tables 4 and 5.
【0089】[0089]
【表4】 ──────────────────────────────── (1)肌のひきしめ感 (2)肌のはり 非常によい 良い 普通 非常によい 良い 普通 ──────────────────────────────── 実施例1 26 11 3 10 20 10 比較例1 3 6 31 5 13 22 ──────────────────────────────── 実施例2 15 19 4 28 8 4 比較例2 7 6 27 5 10 25 ──────────────────────────────── 実施例3 16 17 7 23 15 2 比較例3 4 8 28 7 7 26 ──────────────────────────────── 実施例4 27 12 1 12 18 10 比較例4 3 8 29 6 10 24 ──────────────────────────────── 実施例7 13 18 9 15 18 7 比較例5 3 7 30 2 13 15 ──────────────────────────────── 実施例8 26 13 1 24 8 8 比較例6 3 7 30 8 10 22 ────────────────────────────────[Table 4] ──────────────────────────────── (1) Tightening of the skin (2) Swelling of the skin Very good good average very good good ordinary ──────────────────────────────── Example 1 26 11 3 10 20 10 Comparative Example 1 3 6 31 5 13 22 ──────────────────────────────── Example 2 15 19 4 28 8 4 Comparative Example 2 7 6 27 5 10 25 ──────────────────────────────── Example 3 16 17 7 23 15 2 Comparative Example 3 4 8 28 7 7 26 ──────────────────────────────── Example 4 27 12 1 12 18 10 Comparative Example 4 3 8 29 6 10 24 ──────────────────────────────── Example 7 13 18 9 15 18 7 Comparative Example 5 3 7 30 2 13 15 ──────────────────────────────── Example 8 26 13 1 24 8 8 Comparative Example 6 3 7 30 8 10 22 ────────────────────────────────
【0090】[0090]
【表5】 ──────────────────────────────── (3)肌の弾力感 (4)肌荒れ改善効果 非常によい 良い 普通 非常によい 良い 普通 ──────────────────────────────── 実施例1 15 21 4 28 9 3 比較例1 6 11 23 10 10 20 ──────────────────────────────── 実施例2 24 11 5 25 11 2 比較例2 3 9 28 20 12 8 ──────────────────────────────── 実施例3 22 15 3 25 12 3 比較例3 3 7 20 10 10 20 ──────────────────────────────── 実施例4 15 18 7 13 20 7 比較例4 5 15 20 7 11 22 ──────────────────────────────── 実施例7 12 20 8 30 5 5 比較例5 4 15 21 15 10 15 ──────────────────────────────── 実施例8 25 8 7 32 8 0 比較例6 5 15 20 10 10 20 ────────────────────────────────[Table 5] ──────────────────────────────── (3) Elasticity of the skin (4) Rough skin improving effect Very good good average very good good ordinary ──────────────────────────────── Example 1 15 21 4 28 9 3 Comparative Example 1 6 11 23 10 10 20 ──────────────────────────────── Example 2 24 11 5 25 11 2 Comparative Example 2 3 9 28 20 12 8 ──────────────────────────────── Example 3 22 15 3 25 12 3 Comparative Example 3 3 7 20 10 10 20 ──────────────────────────────── Example 4 15 18 7 13 20 7 Comparative Example 4 5 15 20 7 11 22 ──────────────────────────────── Example 7 12 20 8 30 5 5 Comparative Example 5 4 15 21 15 10 15 ──────────────────────────────── Example 8 25 8 7 32 8 0 Comparative Example 6 5 15 20 10 10 20 ────────────────────────────────
【0091】表4および表5から、本発明の植物抽出物
を含む皮膚外用剤は優れた痩身効果を示すことが明らか
になった。From Tables 4 and 5, it was revealed that the external preparation for skin containing the plant extract of the present invention exhibits an excellent slimming effect.
【0092】[0092]
【発明の効果】以上説明したように、本発明の脂質分解
促進剤及びそれを含有する痩身用皮膚外用剤は、脂質分
解を促進する効果に優れたものである。Industrial Applicability As described above, the lipolysis-promoting agent of the present invention and the slimming skin external preparation containing the same are excellent in the effect of promoting lipolysis.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 35/78 A61K 35/78 V Q B ACN ACNC 35/84 35/84 A Fターム(参考) 4C083 AA011 AA082 AA111 AA122 AB032 AC012 AC022 AC072 AC092 AC102 AC122 AC131 AC132 AC171 AC172 AC182 AC212 AC242 AC302 AC422 AC442 AC482 AC542 AC581 AC582 AC642 AC662 AC851 AC852 AD042 AD112 AD162 AD241 AD242 AD321 AD322 AD332 AD391 AD392 AD512 AD532 AD591 AD592 AD622 AD662 BB51 CC02 CC04 CC05 CC07 DD08 DD23 DD31 DD41 EE12 EE50 FF01 FF05 4C088 AA04 AA12 AA18 AB02 AB12 AB13 AB16 AB18 AB26 AB27 AB30 AB32 AB33 AB36 AB37 AB38 AB40 AB41 AB45 AB50 AB51 AB52 AB62 AB71 AB81 AB85 AB99 BA09 BA10 CA03 MA63 NA14 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 7 Identification code FI theme code (reference) A61K 35/78 A61K 35/78 V Q B ACN ACNC 35/84 35/84 AF term (reference) 4C083 AA011 AA082 AA111 AA122 AB032 AC012 AC022 AC072 AC092 AC102 AC122 AC131 AC132 AC171 AC172 AC182 AC212 AC242 AC302 AC422 AC442 AC482 AC542 AC581 AC582 AC642 AC662 AC851 AC852 AD042 AD112 AD162 AD241 AD242 AD321 AD322 AD332 AD332 AD392 AD512 AD532 AD591 AD592 CC622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD622 AD662 AD622 AD622 AD662 AD662 AD622 AD622 AD622 AD662 AD621 AD622 AD622 AD662 AD621 AD622 AD622 AD622 AD622 AD662 DD23 DD31 DD41 EE12 EE50 FF01 FF05 4C088 AA04 AA12 AA18 AB02 AB12 AB13 AB16 AB18 AB26 AB27 AB30 AB32 AB33 AB36 AB37 AB38 AB40 AB41 AB45 AB50 AB51 AB52 AB62 AB71 AB81 AB85 AB99 BA09 BA10 CA03 MA63 NA14
Claims (3)
クリョウ、キキョウ、ケイカイ、ケイシ、チョレイ、ビ
ャクジュツ、ジオウ、センキュウ、タイソウ、トウキ、
バクモンドウ、ハッカ、タクシャ、ボウフウおよびサン
シュユのうちの一種または二種以上から抽出された抽出
物よりなることを特徴とする脂質分解促進剤。1. Kyonin, peony, tounin, bukuro, kyokyo, Keikai, Keishi, Chorei, juniper, zelkova, senkyu, tanso, touki,
An agent for promoting lipolysis, which comprises an extract extracted from one kind or two or more kinds of Bakumondou, mentha, takusha, bowhu, and Sanshuyu.
クリョウ、キキョウ、ケイカイ、ケイシ、チョレイ、ビ
ャクジュツ、ジオウ、センキュウ、タイソウ、トウキ、
バクモンドウ、ハッカ、タクシャ、ボウフウおよびサン
シュユのうちの一種または二種以上から抽出された抽出
物を有効成分として配合することを特徴とする痩身用皮
膚外用剤。2. Kyonin, peony, Tounin, Bukuro, Kyoukyo, Keikai, Keishi, Chorei, juniper, zelkova, senkyu, tanso, touki,
A slimming skin external preparation comprising an extract, which is extracted from one or more kinds of bakumondou, mentha, takusha, bofu and sanshuyu, as an active ingredient.
クリョウ、キキョウ、ケイカイ、ケイシ、チョレイ、ビ
ャクジュツ、ジオウ、センキュウ、タイソウ、トウキ、
バクモンドウ、ハッカ、タクシャ、ボウフウおよびサン
シュユのうちの一種または二種以上から抽出された抽出
物と、次の(A)から選ばれる一種または二種以上とを
有効成分として配合する請求項2記載の痩身用皮膚外用
剤。 (A)キサンチン誘導体、シソ科ラヴァンドラ属植物抽
出物、セリ科ウイキョウ属植物抽出物、イノシット、デ
キストラン硫酸、海藻抽出物、アミノ酸、エスクロシ
ド、ミカン科植物抽出物、βアドレナリン作用興奮薬、
α2アドレナリン作用抑制薬、ビピリジン誘導体、コシ
ョウ科植物抽出物、アザミ族植物抽出物、茶抽出物、オ
ウレンエキス、オウバクエキス、ベルベリン型アルカロ
イド、イチョウ抽出物、チョウセンニンジン抽出物、タ
イソウエキス、ツボクサエキス、ブッチャーブルームエ
キス、ゼニアオイエキス、ウコンエキス、タイムエキ
ス、アルニカエキス、イチョウエキス、マロニエエキ
ス、トウガラシエキス、キヅタエキス、マンネンロウ、
キンセンカ、サルビア、オトギリソウ、シモツケソウエ
キス、ショウキョウ、ローズマリーエキス、アネトー
ル、サポニン類、スギナエキス、クレマチスエキスおよ
びツヅラフジ科植物抽出物3. Kyonin, peony, Tounin, Bukuro, Kyoukyo, Keikai, Keishi, Chorei, juniper, zelkova, senkyu, tanso, touki,
The extract which is extracted from one or two or more kinds of Bakumondou, mint, takusha, bowfu and sanshuyu, and one or more kinds selected from the following (A) are blended as an active ingredient. Skincare external preparation for slimming. (A) xanthine derivative, Lavandula genus plant extract, Apiaceae fennel plant extract, inosit, dextran sulfate, seaweed extract, amino acid, escroside, citrus plant extract, β-adrenergic stimulant,
α2 adrenergic inhibitor, bipyridine derivative, pepper plant extract, thistle plant extract, tea extract, Coptis extract, Oat extract, Berberine-type alkaloids, Ginkgo biloba extract, Ginseng extract, Pteris chinensis extract, Centella asiatica extract, Butcher bloom extract, mallow extract, turmeric extract, thyme extract, arnica extract, ginkgo extract, horse chestnut extract, capsicum extract, ivy extract, mannen wax,
Calendula, Salvia, St. John's wort, Astragalus extract, Ginger, Rosemary extract, Anethole, Saponins, Horsetail extract, Clematis extract and Amaranthaceae plant extract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10250422A JP2000063227A (en) | 1998-08-20 | 1998-08-20 | Agent for stimulating degradation of lipid and skin preparation for external use and for slimming body |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10250422A JP2000063227A (en) | 1998-08-20 | 1998-08-20 | Agent for stimulating degradation of lipid and skin preparation for external use and for slimming body |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000063227A true JP2000063227A (en) | 2000-02-29 |
Family
ID=17207663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10250422A Withdrawn JP2000063227A (en) | 1998-08-20 | 1998-08-20 | Agent for stimulating degradation of lipid and skin preparation for external use and for slimming body |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000063227A (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000063237A (en) * | 1998-08-21 | 2000-02-29 | Kanebo Ltd | Lipolysis accelerant and skin cosmetic material for thin figure. |
| WO2002005755A1 (en) * | 2000-07-13 | 2002-01-24 | Kawai Cosmetic Co., Ltd | Cosmetic compositions for reducing and method of using the same |
| WO2002051428A1 (en) * | 2000-12-25 | 2002-07-04 | Shiseido Company, Ltd. | Sympathetic-activating perfume composition |
| EP1502598A3 (en) * | 2003-07-29 | 2005-03-30 | Kao Corporation | Lipolysis stimulator |
| JP2006316050A (en) * | 2005-04-13 | 2006-11-24 | Shiseido Co Ltd | Anti-wrinkle agent |
| GB2402676B (en) * | 2003-06-13 | 2007-11-21 | Coletica | Cosmetic use by topical application of the lysyl oxidase-like (LOXL) enzyme to stimulate formation of skin elastic fibres |
| JP2007314438A (en) * | 2006-05-24 | 2007-12-06 | Daicho Kikaku:Kk | Antiobestic medicine |
| JP2008174529A (en) * | 2007-01-22 | 2008-07-31 | Naris Cosmetics Co Ltd | Allergen inactivating agent and skin external preparation containing the same, or allergen inactivating product |
| JP2009051794A (en) * | 2007-08-29 | 2009-03-12 | Ogawa & Co Ltd | Blood flow increase suppressing agent and bathing agent composition containing the blood flow increase suppressing agent |
| JP2009249340A (en) * | 2008-04-07 | 2009-10-29 | Satoshi Shinkawa | Cosmetic composition for slim figure |
| JP2011148837A (en) * | 2003-12-26 | 2011-08-04 | Taisho Pharmaceutical Co Ltd | Lipase inhibitor |
| JP2019119713A (en) * | 2018-01-09 | 2019-07-22 | 共栄化学工業株式会社 | External composition for skin |
| JP2021104950A (en) * | 2019-12-26 | 2021-07-26 | 小林製薬株式会社 | FGF21 production promoter |
-
1998
- 1998-08-20 JP JP10250422A patent/JP2000063227A/en not_active Withdrawn
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000063237A (en) * | 1998-08-21 | 2000-02-29 | Kanebo Ltd | Lipolysis accelerant and skin cosmetic material for thin figure. |
| WO2002005755A1 (en) * | 2000-07-13 | 2002-01-24 | Kawai Cosmetic Co., Ltd | Cosmetic compositions for reducing and method of using the same |
| WO2002051428A1 (en) * | 2000-12-25 | 2002-07-04 | Shiseido Company, Ltd. | Sympathetic-activating perfume composition |
| GB2402676B (en) * | 2003-06-13 | 2007-11-21 | Coletica | Cosmetic use by topical application of the lysyl oxidase-like (LOXL) enzyme to stimulate formation of skin elastic fibres |
| EP1502598A3 (en) * | 2003-07-29 | 2005-03-30 | Kao Corporation | Lipolysis stimulator |
| JP2011148837A (en) * | 2003-12-26 | 2011-08-04 | Taisho Pharmaceutical Co Ltd | Lipase inhibitor |
| JP2006316050A (en) * | 2005-04-13 | 2006-11-24 | Shiseido Co Ltd | Anti-wrinkle agent |
| JP2007314438A (en) * | 2006-05-24 | 2007-12-06 | Daicho Kikaku:Kk | Antiobestic medicine |
| JP2008174529A (en) * | 2007-01-22 | 2008-07-31 | Naris Cosmetics Co Ltd | Allergen inactivating agent and skin external preparation containing the same, or allergen inactivating product |
| JP2009051794A (en) * | 2007-08-29 | 2009-03-12 | Ogawa & Co Ltd | Blood flow increase suppressing agent and bathing agent composition containing the blood flow increase suppressing agent |
| JP2009249340A (en) * | 2008-04-07 | 2009-10-29 | Satoshi Shinkawa | Cosmetic composition for slim figure |
| JP2019119713A (en) * | 2018-01-09 | 2019-07-22 | 共栄化学工業株式会社 | External composition for skin |
| JP7246605B2 (en) | 2018-01-09 | 2023-03-28 | 共栄化学工業株式会社 | Skin topical composition |
| JP2021104950A (en) * | 2019-12-26 | 2021-07-26 | 小林製薬株式会社 | FGF21 production promoter |
| JP7519650B2 (en) | 2019-12-26 | 2024-07-22 | 小林製薬株式会社 | FGF21 production promoter |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5698199A (en) | Lipolysis acceleration method | |
| CN102342993B (en) | Anti-sensitization and restoration external preparation for skin | |
| JPH1036279A (en) | Fibroblast proliferation promoting agent containing vegetable extract | |
| JP2005060366A (en) | Lipolysis accelerator | |
| JP4104180B2 (en) | Lipase activity promoter | |
| JP2000063227A (en) | Agent for stimulating degradation of lipid and skin preparation for external use and for slimming body | |
| US20230042135A1 (en) | Herbal shampoo composition and method for preparing the same | |
| JP2000063260A (en) | Lipid decomposition accelerator and skin preparation for external use for weight reduction | |
| JPH08208451A (en) | Whitening agent containing herbal extracts | |
| JP2000063259A (en) | Lipolysis accelerating agent and skin preparation for external use for weight reduction | |
| JP2004010526A (en) | External preparation for skin | |
| CN105496830A (en) | Preparation method of alpinia japonica extract and application thereof in personal care products | |
| JPH11269079A (en) | Preparation for external use for skin for promoting lipid degradation | |
| JP4047441B2 (en) | Lipid degradation promoter and slimming skin external preparation | |
| JP5863225B2 (en) | Skin care composition | |
| JP2016530328A (en) | A composition comprising an extract of a mixed herb consisting of Acantopanax KOREANUM NAKAI and Hamamoto (CRINUM ASIATICUM VAR. JAPONICUM) exhibiting baldness prevention activity and hair growth stimulating activity | |
| JP2019058144A (en) | Slimming food and external preparation composition | |
| JP4828077B2 (en) | Topical skin preparation | |
| JP2012229266A (en) | Lipolysis promotor | |
| KR101740970B1 (en) | Topical composition comprising the herbal mixed extract including phytoncide of Chamaecyparis obtusa showing hair-growth stimulating activity and preventing effect on hair loss | |
| JP2004224785A (en) | Collagen production accelerator | |
| JP4585227B2 (en) | Slimming kit | |
| JP2003306410A (en) | Powder-containing water-in-oil emulsion cosmetic | |
| KR20130033624A (en) | Topical composition comprising the herbal mixed extract including pleuropterus multiflorus turcz showing hair-growth stimulating activity and preventing effect on hair loss | |
| JP2005289999A (en) | Cosmetic composition comprising jujube extract and walnut extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20051101 |